LATS1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00170 | S43 | Sugiyama | AIP XAP2 | GELPDFQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELI |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15013 | S1304 | Sugiyama | ARHGEF10 KIAA0294 | ssGsLsLsHGsssLEHRSEDsTIyDLLKDPVSLRSKARRAK |
| O43175 | S12 | Sugiyama | PHGDH PGDH3 | _________MAFANLRKVLIsDsLDPCCRKILQDGGLQVVE |
| O43623 | T208 | PSP | SNAI2 SLUG SLUGH | KICGKAFSRPWLLQGHIRTHtGEKPFSCPHCNRAFADRSNL |
| O60841 | S107 | Sugiyama | EIF5B IF2 KIAA0741 | NEEEFtsKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTA |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75874 | S9 | Sugiyama | IDH1 PICD | ____________MSKKIsGGsVVEMQGDEMTRIIWELIKEK |
| O94885 | S407 | PSP | SASH1 KIAA0790 PEPE1 | sLtEGEMKKGLGSLSHGRtCsFGGFDLTNRSLHVGSNNSDP |
| O95633 | T228 | Sugiyama | FSTL3 FLRG UNQ674/PRO1308 | QELCGNNNVTYISSCHMRQAtCFLGRSIGVRHAGSCAGTPE |
| O95721 | S204 | Sugiyama | SNAP29 | MSTDAYPKNPHLRAYHQKIDsNLDELsMGLGRLKDIALGMQ |
| O95835 | S1016 | Sugiyama | LATS1 WARTS | LGKNGADEIKAHPFFKtIDFsSDLRQQSASYIPKITHPTDT |
| O95835 | S1049 | EPSD|PSP | LATS1 WARTS | KITHPTDTSNFDPVDPDKLWsDDNEEENVNDtLNGWYKNGK |
| O95835 | S593 | Sugiyama | LATS1 WARTS | yEsISKPSKEDQPSLPKEDEsEKSYENVDSGDKEKKQItts |
| O95835 | S613 | Sugiyama | LATS1 WARTS | sEKSYENVDSGDKEKKQIttsPItVRKNKKDEERRESRIQS |
| O95835 | S674 | EPSD|PSP|Sugiyama | LATS1 WARTS | HQQRLHRKKQLENEMMRVGLsQDAQDQMRKMLCQKESNYIR |
| O95835 | S864 | Sugiyama | LATS1 WARTS | LTDFGLCTGFRWTHDSKYYQsGDHPRQDsMDFsNEWGDPSS |
| O95835 | S872 | Sugiyama | LATS1 WARTS | GFRWTHDSKYYQsGDHPRQDsMDFsNEWGDPSSCRCGDRLK |
| O95835 | S876 | Sugiyama | LATS1 WARTS | THDSKYYQsGDHPRQDsMDFsNEWGDPSSCRCGDRLKPLER |
| O95835 | S909 | EPSD|PSP | LATS1 WARTS | DRLKPLERRAARQHQRCLAHsLVGTPNYIAPEVLLRTGYTQ |
| O95835 | T1060 | Sugiyama | LATS1 WARTS | DPVDPDKLWsDDNEEENVNDtLNGWYKNGKHPEHAFYEFtF |
| O95835 | T1079 | Sugiyama | LATS1 WARTS | DtLNGWYKNGKHPEHAFYEFtFRRFFDDNGYPYNYPKPIEY |
| O95835 | T616 | Sugiyama | LATS1 WARTS | SYENVDSGDKEKKQIttsPItVRKNKKDEERRESRIQSYsP |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P04049 | S259 | EPSD|PSP | RAF1 RAF | tFNtssPSSEGSLSQRQRststPNVHMVsttLPVDSRMIED |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04632 | T85 | Sugiyama | CAPNS1 CAPN4 CAPNS | VIsAISEAAAQYNPEPPPPRtHysNIEANEsEEVRQFRRLF |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S83 | Sugiyama | HSPB1 HSP27 HSP28 | IEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNH |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09661 | S212 | Sugiyama | SNRPA1 | KKGGPsPGDVEAIKNAIANAstLAEVERLKGLLQsGQIPGR |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11387 | S10 | Sugiyama | TOP1 | ___________MsGDHLHNDsQIEADFRLNDsHKHKDKHKD |
| P11908 | T285 | SIGNOR|PSP | PRPS2 | AFEAVVVTNTIPQEDKMKHCtKIQVIDISMILAEAIRRTHN |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P13010 | S318 | Sugiyama | XRCC5 G22P2 | NDDDETEVLKEDIIQGFRyGsDIVPFSKVDEEQMKYKSEGK |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P22059 | S190 | Sugiyama | OSBP OSBP1 | QRWVTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNT |
| P22059 | S193 | Sugiyama | OSBP OSBP1 | VTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNTLRT |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P29692 | S74 | Sugiyama | EEF1D EF1D | RENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVENQsL |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | S54 | Sugiyama | PEBP1 PBP PEBP | VDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAP |
| P30101 | Y356 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FVMQEEFsRDGKALERFLQDyFDGNLKRyLKsEPIPESNDG |
| P31153 | Y235 | Sugiyama | MAT2A AMS2 MATA2 | LDEMRDALKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGP |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33176 | S950 | Sugiyama | KIF5B KNS KNS1 | PAAsPtHPSAIRGGGAFVQNsQPVAVRGGGGKQV_______ |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P40855 | S147 | Sugiyama | PEX19 HK33 PXF OK/SW-cl.22 | SCLKETLSGLAKNATDLQNssMsEEELTKAMEGLGMDEGDG |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S195 | Sugiyama | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46937 | S109 | GPS6|EPSD|PSP|Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P46937 | S127 | GPS6|SIGNOR|EPSD|PSP | YAP1 YAP65 | QAstDAGtAGALtPQHVRAHssPAsLQLGAVsPGtLtPtGV |
| P46937 | S164 | GPS6|EPSD|PSP | YAP1 YAP65 | PtGVVsGPAAtPTAQHLRQssFEIPDDVPLPAGWEMAKTSS |
| P46937 | S381 | PSP | YAP1 YAP65 | tQNPVssPGMsQELRTMttNssDPFLNsGtyHsRDEstDsG |
| P46937 | S397 | GPS6|SIGNOR|EPSD | YAP1 YAP65 | MttNssDPFLNsGtyHsRDEstDsGLsMssysVPRtPDDFL |
| P46937 | S400 | Sugiyama | YAP1 YAP65 | NssDPFLNsGtyHsRDEstDsGLsMssysVPRtPDDFLNsV |
| P46937 | S61 | GPS6|EPSD|PSP | YAP1 YAP65 | tQAAPQAPPAGHQIVHVRGDsEtDLEALFNAVMNPKtANVP |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49321 | S659 | Sugiyama | NASP | IEELKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsst |
| P50990 | S23 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | LHVPKAPGFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTT |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | T598 | Sugiyama | FXR2 FMR1L2 | DESRPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRA |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60891 | S285 | SIGNOR|PSP | PRPS1 | CFEAVVVTNTIPQEDKMKHCsKIQVIDISMILAEAIRRTHN |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01650 | S31 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | LAAPAAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNIT |
| Q02241 | S716 | EPSD|PSP | KIF23 KNSL5 MKLP1 | AQISNGQQLMSQPQLHRRsNsCssISVASCISEWEQKIPTy |
| Q02241 | S814 | EPSD|PSP | KIF23 KNSL5 MKLP1 | LLFQPDQNAPPIRLRHRRsRsAGDRWVDHKPASNMQTETVM |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q07021 | T214 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | GQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDSLDWA |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q13155 | S48 | Sugiyama | AIMP2 JTV1 PRO0992 | PNVHGRSyGPAPGAGHVQEEsNLsLQALESRQDDILKRLYE |
| Q13283 | S67 | Sugiyama | G3BP1 G3BP | sNGKPADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLN |
| Q13283 | T71 | Sugiyama | G3BP1 G3BP | PADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLNDGVV |
| Q13283 | Y19 | Sugiyama | G3BP1 G3BP | __MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNss |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q14103 | S271 | Sugiyama | HNRNPD AUF1 HNRPD | KCEIKVAMSKEQyQQQQQWGsRGGFAGRARGRGGGPSQNWN |
| Q14152 | S1256 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EDRFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRE |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14669 | S987 | Sugiyama | TRIP12 KIAA0045 ULF | AAtHAAADLGsPSLQHSRDDsLDLsPQGRLsDVLKRKRLPK |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14872 | S152 | SIGNOR|PSP | MTF1 | TKRKEVKRYQCTFEGCPRTYsTAGNLRTHQKTHRGEYTFVC |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15293 | Y115 | Sugiyama | RCN1 RCN | GDGFVttEELKtWIKRVQKRyIFDNVAKVWKDYDRDKDDKI |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16576 | S163 | Sugiyama | RBBP7 RBAP46 | tPssDVLVFDyTKHPAKPDPsGECNPDLRLRGHQKEGYGLS |
| Q16584 | T477 | PSP | MAP3K11 MLK3 PTK1 SPRK | LTLLLQQVDRERPHVRRRRGtFKRSKLRARDGGERISMPLD |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q4VCS5 | S175 | SIGNOR|PSP | AMOT KIAA1071 | GKMHQDEGLRDLKQGHVRSLsERLMQMSLATSGVKAHPPVT |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q5H9R7 | S579 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | IDQFGFNDEKFADQDDIGNVsFDRVSDINFTLNTNESGNIA |
| Q5T5C0 | S692 | Sugiyama | STXBP5 LLGL3 | YGSNDPYRREPRSPRKsRQPsGAGLCDIsEGtVVPEDRCKS |
| Q674X7 | S318 | Sugiyama | KAZN C1orf196 KAZ KIAA1026 HRIHFB2003 | PPHPADRQAVRVsPCHSRQPsVISDASAAEGDRsstPSDIN |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z417 | S655 | Sugiyama | NUFIP2 KIAA1321 PIG1 | LGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsIWNL |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8N122 | S606 | PSP | RPTOR KIAA1303 RAPTOR | QNFDSARWCGVRDSAHEKLYsLLSDPIPEVRCAAVFALGTF |
| Q8NHZ8 | T7 | SIGNOR|EPSD|PSP | CDC26 ANAPC12 C9orf17 | ______________MLRRKPtRLELKLDDIEEFENIRKDLE |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8WWI1 | S709 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | VERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEMQKIKS |
| Q8WX93 | S479 | Sugiyama | PALLD KIAA0992 CGI-151 | VLECRVRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAE |
| Q92769 | S422 | Sugiyama | HDAC2 | PDKRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGA |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99614 | S90 | Sugiyama | TTC1 TPR1 | FEEEPGADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQ |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BTU6 | S460 | Sugiyama | PI4K2A | PLHLVQMPPVIVETARSHQRsssEsyTQsFQSRKPFFSWW_ |
| Q9BTU6 | S462 | Sugiyama | PI4K2A | HLVQMPPVIVETARSHQRsssEsyTQsFQSRKPFFSWW___ |
| Q9BY44 | S526 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | sPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKA |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9C0C2 | S920 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QDANEQGQDLGKRDHHGRyssQDADEQDWEFQKRDVsLGTy |
| Q9GZV5 | S89 | SIGNOR|PSP | WWTR1 TAZ | SsGGHPGPRLAGGAQHVRsHssPAsLQLGtGAGAAGsPAQQ |
| Q9NPD3 | S240 | Sugiyama | EXOSC4 RRP41 SKI6 | AARDVHTLLDRVVRQHVREAsILLGD_______________ |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQS7 | S894 | EPSD|PSP | INCENP | PLDLEDIFKKSKPRYHKRtssAVWNsPPLQGARVPssLAYs |
| Q9NRM7 | T1041 | Sugiyama | LATS2 KPM | AWDtLtsPNNKHPEHAFYEFtFRRFFDDNGyPFRCPKPSGA |
| Q9NZN8 | S242 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | VTGLDLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMV |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y5U2 | S86 | Sugiyama | TSSC4 | PSPPSGLLPATVQPFHLRGMssTFSQRsRDIFDCLEGAARR |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signaling by Hippo | R-HSA-2028269 | 7.024593e-07 | 6.153 | 1 | 1 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.410560e-05 | 4.851 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.578956e-05 | 4.120 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.504602e-04 | 3.601 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.087168e-04 | 3.680 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.210173e-04 | 3.656 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.030653e-04 | 3.518 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.046622e-04 | 3.393 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.046622e-04 | 3.393 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.365826e-04 | 3.360 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.987149e-04 | 3.399 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.681860e-04 | 3.330 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.204052e-04 | 3.284 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.227323e-04 | 3.206 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.134820e-03 | 2.945 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.199366e-03 | 2.921 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.171130e-03 | 2.931 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.142845e-03 | 2.942 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.416369e-03 | 2.849 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.323593e-03 | 2.878 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.371099e-03 | 2.863 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.732158e-03 | 2.761 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.766651e-03 | 2.753 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.112262e-03 | 2.675 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.092448e-03 | 2.679 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.112262e-03 | 2.675 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.442453e-03 | 2.612 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.743899e-03 | 2.562 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.919289e-03 | 2.535 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.968623e-03 | 2.527 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.834370e-03 | 2.416 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.830168e-03 | 2.417 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.565767e-03 | 2.448 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.695029e-03 | 2.432 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.830168e-03 | 2.417 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.893891e-03 | 2.410 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.259236e-03 | 2.371 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.441518e-03 | 2.352 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.820309e-03 | 2.317 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.959724e-03 | 2.305 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.658522e-03 | 2.247 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.793914e-03 | 2.237 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.820144e-03 | 2.235 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 5.820147e-03 | 2.235 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.104393e-03 | 2.214 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.219596e-03 | 2.206 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.377029e-03 | 2.195 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.117188e-03 | 2.148 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.915718e-03 | 2.160 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.117188e-03 | 2.148 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.272152e-03 | 2.138 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 7.491261e-03 | 2.125 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.536809e-03 | 2.123 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.107312e-03 | 2.091 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.414125e-03 | 2.075 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.010134e-02 | 1.996 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.779852e-03 | 2.010 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.066537e-02 | 1.972 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.022789e-02 | 1.990 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.045567e-02 | 1.981 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.051029e-02 | 1.978 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.073332e-02 | 1.969 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.209822e-02 | 1.917 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.160355e-02 | 1.935 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.209822e-02 | 1.917 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.229733e-02 | 1.910 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.418783e-02 | 1.848 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.418783e-02 | 1.848 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.418783e-02 | 1.848 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.418783e-02 | 1.848 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.467711e-02 | 1.833 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.318325e-02 | 1.880 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.418783e-02 | 1.848 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.433783e-02 | 1.844 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.354682e-02 | 1.868 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.506788e-02 | 1.822 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.580052e-02 | 1.801 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.163133e-02 | 1.665 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 2.163133e-02 | 1.665 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.163133e-02 | 1.665 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.163133e-02 | 1.665 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.163133e-02 | 1.665 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.163133e-02 | 1.665 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.163133e-02 | 1.665 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.163133e-02 | 1.665 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.163133e-02 | 1.665 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.163133e-02 | 1.665 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.163133e-02 | 1.665 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.163133e-02 | 1.665 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.163133e-02 | 1.665 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.163133e-02 | 1.665 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.932112e-02 | 1.714 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.932112e-02 | 1.714 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.628667e-02 | 1.788 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.628667e-02 | 1.788 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.807051e-02 | 1.743 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.151478e-02 | 1.667 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.187031e-02 | 1.660 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.906901e-02 | 1.720 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.998736e-02 | 1.699 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.042935e-02 | 1.690 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.906488e-02 | 1.720 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.906488e-02 | 1.720 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.879567e-02 | 1.726 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.879567e-02 | 1.726 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.770029e-02 | 1.752 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.310564e-02 | 1.636 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.355941e-02 | 1.628 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.402321e-02 | 1.619 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.402321e-02 | 1.619 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.423761e-02 | 1.616 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.469313e-02 | 1.607 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.493089e-02 | 1.603 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.493089e-02 | 1.603 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.503372e-02 | 1.601 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.765216e-02 | 1.558 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.723025e-02 | 1.565 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 2.765216e-02 | 1.558 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.960831e-02 | 1.529 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.960831e-02 | 1.529 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.078669e-02 | 1.512 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.165032e-02 | 1.500 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.165032e-02 | 1.500 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.165032e-02 | 1.500 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.184377e-02 | 1.497 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.184377e-02 | 1.497 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.258839e-02 | 1.487 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.258839e-02 | 1.487 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.570686e-02 | 1.447 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.226280e-02 | 1.491 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.269508e-02 | 1.486 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.598342e-02 | 1.444 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.639284e-02 | 1.439 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 4.525457e-02 | 1.344 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.525457e-02 | 1.344 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.525457e-02 | 1.344 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.759466e-02 | 1.425 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.510380e-02 | 1.346 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.181969e-02 | 1.379 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.984666e-02 | 1.400 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.984666e-02 | 1.400 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.984666e-02 | 1.400 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.426623e-02 | 1.354 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.426623e-02 | 1.354 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.947680e-02 | 1.404 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.709007e-02 | 1.327 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.059707e-02 | 1.392 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.313858e-02 | 1.365 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.158849e-02 | 1.381 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.712754e-02 | 1.327 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.201922e-02 | 1.377 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.201922e-02 | 1.377 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.317819e-02 | 1.365 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.960422e-02 | 1.402 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.525457e-02 | 1.344 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.946365e-02 | 1.404 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.219577e-02 | 1.375 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.133105e-02 | 1.384 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 4.525457e-02 | 1.344 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.181969e-02 | 1.379 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.317819e-02 | 1.365 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.022002e-02 | 1.396 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.317819e-02 | 1.365 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.619359e-02 | 1.335 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.759466e-02 | 1.425 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.984666e-02 | 1.400 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.751864e-02 | 1.323 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.861937e-02 | 1.313 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.938678e-02 | 1.306 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.938678e-02 | 1.306 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 5.447613e-02 | 1.264 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 5.447613e-02 | 1.264 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.941157e-02 | 1.226 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.941157e-02 | 1.226 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.941157e-02 | 1.226 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.329573e-02 | 1.273 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.395212e-02 | 1.268 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.921990e-02 | 1.228 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.921990e-02 | 1.228 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.121443e-02 | 1.291 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.121443e-02 | 1.291 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.121443e-02 | 1.291 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.871418e-02 | 1.231 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.619366e-02 | 1.250 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.559974e-02 | 1.255 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.862527e-02 | 1.232 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.395212e-02 | 1.268 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.707105e-02 | 1.244 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.121443e-02 | 1.291 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.711447e-02 | 1.243 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.362565e-02 | 1.271 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.962269e-02 | 1.225 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.980984e-02 | 1.223 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.980984e-02 | 1.223 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.214773e-02 | 1.207 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.214773e-02 | 1.207 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.214773e-02 | 1.207 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.214773e-02 | 1.207 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.214773e-02 | 1.207 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.214773e-02 | 1.207 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 7.485974e-02 | 1.126 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 7.485974e-02 | 1.126 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 7.485974e-02 | 1.126 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 7.485974e-02 | 1.126 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 7.485974e-02 | 1.126 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.163353e-02 | 1.145 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.060211e-02 | 1.151 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.164084e-02 | 1.145 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.435210e-02 | 1.129 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.163353e-02 | 1.145 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.505791e-02 | 1.125 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.476047e-02 | 1.189 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.236071e-02 | 1.140 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.060211e-02 | 1.151 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.448366e-02 | 1.128 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.485974e-02 | 1.126 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.060211e-02 | 1.151 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.747234e-02 | 1.171 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.163353e-02 | 1.145 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.435210e-02 | 1.129 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.535992e-02 | 1.123 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.485974e-02 | 1.126 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.521270e-02 | 1.186 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.485974e-02 | 1.126 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.060211e-02 | 1.151 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.747234e-02 | 1.171 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.571217e-02 | 1.121 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.671280e-02 | 1.115 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.671280e-02 | 1.115 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.898825e-02 | 1.102 | 1 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.204762e-02 | 1.086 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.279250e-02 | 1.082 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.309937e-02 | 1.080 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.609652e-02 | 1.065 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.609652e-02 | 1.065 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.609652e-02 | 1.065 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.609652e-02 | 1.065 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 8.609652e-02 | 1.065 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.609652e-02 | 1.065 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 8.612586e-02 | 1.065 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 8.612586e-02 | 1.065 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.619315e-02 | 1.065 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.059877e-01 | 0.975 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.059877e-01 | 0.975 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.059877e-01 | 0.975 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.059877e-01 | 0.975 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.059877e-01 | 0.975 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.059877e-01 | 0.975 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.059877e-01 | 0.975 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 9.141674e-02 | 1.039 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 9.141674e-02 | 1.039 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 9.238759e-02 | 1.034 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 9.010296e-02 | 1.045 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 9.010296e-02 | 1.045 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 8.975800e-02 | 1.047 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.078330e-01 | 0.967 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.078330e-01 | 0.967 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.477237e-02 | 1.023 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 9.129850e-02 | 1.040 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.018346e-01 | 0.992 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.010296e-02 | 1.045 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.042276e-01 | 0.982 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.042276e-01 | 0.982 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 8.667725e-02 | 1.062 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 9.898239e-02 | 1.004 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.076776e-01 | 0.968 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 9.852957e-02 | 1.006 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.038726e-01 | 0.983 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 9.930246e-02 | 1.003 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.871911e-02 | 1.052 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 9.884008e-02 | 1.005 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 9.141674e-02 | 1.039 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 9.238759e-02 | 1.034 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 9.238759e-02 | 1.034 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.898239e-02 | 1.004 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 9.010296e-02 | 1.045 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 9.010296e-02 | 1.045 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.089162e-01 | 0.963 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.089162e-01 | 0.963 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.089162e-01 | 0.963 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.089162e-01 | 0.963 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.090917e-01 | 0.962 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.091967e-01 | 0.962 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.113175e-01 | 0.953 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.125313e-01 | 0.949 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.153002e-01 | 0.938 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.153002e-01 | 0.938 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.164254e-01 | 0.934 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.546959e-01 | 0.811 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 1.546959e-01 | 0.811 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 1.546959e-01 | 0.811 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 1.546959e-01 | 0.811 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 1.546959e-01 | 0.811 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.546959e-01 | 0.811 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.272066e-01 | 0.895 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.461501e-01 | 0.835 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.461501e-01 | 0.835 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.274792e-01 | 0.895 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.274792e-01 | 0.895 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.400924e-01 | 0.854 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.258678e-01 | 0.900 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.258678e-01 | 0.900 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.356208e-01 | 0.868 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.356208e-01 | 0.868 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.456691e-01 | 0.837 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.384395e-01 | 0.859 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.534255e-01 | 0.814 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.386592e-01 | 0.858 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.456691e-01 | 0.837 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.435250e-01 | 0.843 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.461501e-01 | 0.835 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.400924e-01 | 0.854 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.239545e-01 | 0.907 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 1.461501e-01 | 0.835 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.461501e-01 | 0.835 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.492825e-01 | 0.826 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.555448e-01 | 0.808 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.244658e-01 | 0.905 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.514062e-01 | 0.820 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.351239e-01 | 0.869 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.386592e-01 | 0.858 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.461501e-01 | 0.835 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.521453e-01 | 0.818 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.356208e-01 | 0.868 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.531035e-01 | 0.815 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.190124e-01 | 0.924 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.272066e-01 | 0.895 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.400924e-01 | 0.854 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.279772e-01 | 0.893 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.224117e-01 | 0.912 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.414512e-01 | 0.849 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.168962e-01 | 0.932 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.469048e-01 | 0.833 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.557752e-01 | 0.808 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.357611e-01 | 0.867 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.422332e-01 | 0.847 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.546959e-01 | 0.811 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.400924e-01 | 0.854 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.534255e-01 | 0.814 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.404048e-01 | 0.853 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.435250e-01 | 0.843 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.269504e-01 | 0.896 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.351239e-01 | 0.869 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.199022e-01 | 0.921 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.461501e-01 | 0.835 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.272066e-01 | 0.895 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.190124e-01 | 0.924 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.456691e-01 | 0.837 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.559970e-01 | 0.807 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.559970e-01 | 0.807 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.563765e-01 | 0.806 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.589952e-01 | 0.799 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.609761e-01 | 0.793 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.649783e-01 | 0.783 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.656213e-01 | 0.781 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.656213e-01 | 0.781 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.656213e-01 | 0.781 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.656213e-01 | 0.781 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.664766e-01 | 0.779 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.665885e-01 | 0.778 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.678492e-01 | 0.775 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.678492e-01 | 0.775 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.678492e-01 | 0.775 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 2.007532e-01 | 0.697 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 2.007532e-01 | 0.697 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.443036e-01 | 0.612 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.443036e-01 | 0.612 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.443036e-01 | 0.612 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.854834e-01 | 0.544 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 2.854834e-01 | 0.544 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.854834e-01 | 0.544 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.854834e-01 | 0.544 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.854834e-01 | 0.544 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.855069e-01 | 0.732 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.244216e-01 | 0.489 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.244216e-01 | 0.489 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.261197e-01 | 0.646 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.261197e-01 | 0.646 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.612401e-01 | 0.442 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 3.612401e-01 | 0.442 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.612401e-01 | 0.442 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 3.612401e-01 | 0.442 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.612401e-01 | 0.442 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.612401e-01 | 0.442 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.612401e-01 | 0.442 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.612401e-01 | 0.442 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.466705e-01 | 0.608 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.466705e-01 | 0.608 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.801759e-01 | 0.744 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.801759e-01 | 0.744 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.941662e-01 | 0.712 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.941662e-01 | 0.712 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 2.672812e-01 | 0.573 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.672812e-01 | 0.573 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.672812e-01 | 0.573 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.960541e-01 | 0.402 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.878842e-01 | 0.541 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.878842e-01 | 0.541 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.878842e-01 | 0.541 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.375420e-01 | 0.624 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.084194e-01 | 0.511 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 4.289726e-01 | 0.368 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.289726e-01 | 0.368 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.289726e-01 | 0.368 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 4.289726e-01 | 0.368 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.288330e-01 | 0.483 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.673056e-01 | 0.573 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.690939e-01 | 0.772 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.490774e-01 | 0.457 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.490774e-01 | 0.457 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.600987e-01 | 0.337 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.600987e-01 | 0.337 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.600987e-01 | 0.337 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.600987e-01 | 0.337 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.600987e-01 | 0.337 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.600987e-01 | 0.337 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.684352e-01 | 0.774 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.483512e-01 | 0.605 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.895300e-01 | 0.310 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.895300e-01 | 0.310 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.895300e-01 | 0.310 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.817938e-01 | 0.740 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 4.275940e-01 | 0.369 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.120715e-01 | 0.506 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.348190e-01 | 0.629 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.348190e-01 | 0.629 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.882251e-01 | 0.411 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.464558e-01 | 0.350 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 4.464558e-01 | 0.350 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.633397e-01 | 0.579 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.633397e-01 | 0.579 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.649639e-01 | 0.333 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.649639e-01 | 0.333 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.649639e-01 | 0.333 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.326841e-01 | 0.364 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 2.678433e-01 | 0.572 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.386885e-01 | 0.470 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 4.455018e-01 | 0.351 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.698148e-01 | 0.328 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.818243e-01 | 0.317 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 2.802686e-01 | 0.552 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.277995e-01 | 0.484 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.021695e-01 | 0.520 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.022884e-01 | 0.694 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.275940e-01 | 0.369 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.708933e-01 | 0.431 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.997778e-01 | 0.699 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.732038e-01 | 0.428 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.587528e-01 | 0.587 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.083990e-01 | 0.389 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.798487e-01 | 0.553 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.903840e-01 | 0.309 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.700084e-01 | 0.770 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.277995e-01 | 0.484 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 3.882251e-01 | 0.411 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.288330e-01 | 0.483 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.691104e-01 | 0.433 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.984359e-01 | 0.702 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.084129e-01 | 0.681 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.084194e-01 | 0.511 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.430601e-01 | 0.354 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.899729e-01 | 0.310 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 2.974645e-01 | 0.527 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.984359e-01 | 0.702 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.229148e-01 | 0.652 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 4.962738e-01 | 0.304 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 2.261197e-01 | 0.646 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.612401e-01 | 0.442 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.612401e-01 | 0.442 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.466705e-01 | 0.608 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.289726e-01 | 0.368 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.523599e-01 | 0.598 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.429701e-01 | 0.465 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.008517e-01 | 0.300 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.899729e-01 | 0.310 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.732038e-01 | 0.428 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.266351e-01 | 0.486 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.266351e-01 | 0.486 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.229148e-01 | 0.652 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.287236e-01 | 0.368 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.457175e-01 | 0.461 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.261197e-01 | 0.646 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.519210e-01 | 0.454 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.229268e-01 | 0.491 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.323327e-01 | 0.478 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.854834e-01 | 0.544 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.854834e-01 | 0.544 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.855069e-01 | 0.732 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.244216e-01 | 0.489 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.244216e-01 | 0.489 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.057040e-01 | 0.687 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 2.261197e-01 | 0.646 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 3.084194e-01 | 0.511 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 3.084194e-01 | 0.511 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 4.289726e-01 | 0.368 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.347357e-01 | 0.629 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.277995e-01 | 0.484 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.895300e-01 | 0.310 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.957008e-01 | 0.529 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.081537e-01 | 0.511 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.130786e-01 | 0.671 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.123671e-01 | 0.505 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.278441e-01 | 0.369 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.130786e-01 | 0.671 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.347357e-01 | 0.629 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.057040e-01 | 0.687 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.261197e-01 | 0.646 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.380608e-01 | 0.623 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.698148e-01 | 0.328 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.750576e-01 | 0.757 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.079343e-01 | 0.512 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.713540e-01 | 0.766 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 4.289726e-01 | 0.368 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 3.888951e-01 | 0.410 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.732038e-01 | 0.428 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.558925e-01 | 0.449 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.937733e-01 | 0.713 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.467283e-01 | 0.608 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.645431e-01 | 0.333 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.645431e-01 | 0.333 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.899729e-01 | 0.310 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.899729e-01 | 0.310 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.229148e-01 | 0.652 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.895300e-01 | 0.310 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.288330e-01 | 0.483 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.083990e-01 | 0.389 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.229148e-01 | 0.652 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.464558e-01 | 0.350 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.717612e-01 | 0.326 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 2.007532e-01 | 0.697 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.854834e-01 | 0.544 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.244216e-01 | 0.489 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 3.612401e-01 | 0.442 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 3.612401e-01 | 0.442 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.612401e-01 | 0.442 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.466705e-01 | 0.608 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.884956e-01 | 0.725 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.289726e-01 | 0.368 | 0 | 0 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 4.289726e-01 | 0.368 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.792327e-01 | 0.747 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.600987e-01 | 0.337 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.600987e-01 | 0.337 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.600987e-01 | 0.337 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.600987e-01 | 0.337 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.974645e-01 | 0.527 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.937733e-01 | 0.713 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.691104e-01 | 0.433 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.888951e-01 | 0.410 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.895300e-01 | 0.310 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.895300e-01 | 0.310 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.464558e-01 | 0.350 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.600745e-01 | 0.585 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.751650e-01 | 0.757 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.549161e-01 | 0.594 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.457585e-01 | 0.461 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.467283e-01 | 0.608 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.833137e-01 | 0.548 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.515444e-01 | 0.599 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.271251e-01 | 0.644 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.021695e-01 | 0.520 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.042080e-01 | 0.297 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.289951e-01 | 0.368 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.457585e-01 | 0.461 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.229148e-01 | 0.652 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.594217e-01 | 0.338 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.286010e-01 | 0.641 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.678433e-01 | 0.572 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.718058e-01 | 0.765 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.179822e-01 | 0.379 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 2.466705e-01 | 0.608 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.347357e-01 | 0.629 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.155357e-01 | 0.501 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.905225e-01 | 0.537 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.839450e-01 | 0.735 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.352568e-01 | 0.628 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.913076e-01 | 0.407 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.913076e-01 | 0.407 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.854834e-01 | 0.544 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.289726e-01 | 0.368 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.289726e-01 | 0.368 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.600987e-01 | 0.337 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.936324e-01 | 0.532 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.649639e-01 | 0.333 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.751921e-01 | 0.323 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.022884e-01 | 0.694 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 1.690939e-01 | 0.772 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.974645e-01 | 0.527 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.895300e-01 | 0.310 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.250283e-01 | 0.488 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.372551e-01 | 0.359 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.817163e-01 | 0.741 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.084194e-01 | 0.511 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.435243e-01 | 0.353 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.236447e-01 | 0.490 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.899729e-01 | 0.310 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.899729e-01 | 0.310 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.801759e-01 | 0.744 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.008862e-01 | 0.697 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.913076e-01 | 0.407 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.735702e-01 | 0.325 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 2.007532e-01 | 0.697 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 2.443036e-01 | 0.612 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 2.854834e-01 | 0.544 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.878842e-01 | 0.541 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 4.289726e-01 | 0.368 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.289726e-01 | 0.368 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.600987e-01 | 0.337 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.691104e-01 | 0.433 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.277995e-01 | 0.484 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.888951e-01 | 0.410 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.888951e-01 | 0.410 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 4.895300e-01 | 0.310 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.732038e-01 | 0.428 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.338231e-01 | 0.476 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.031571e-01 | 0.395 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.692278e-01 | 0.570 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.692278e-01 | 0.570 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.692278e-01 | 0.570 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.758944e-01 | 0.322 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.331969e-01 | 0.477 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.052298e-01 | 0.515 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.229148e-01 | 0.652 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.455018e-01 | 0.351 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.900130e-01 | 0.538 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.829262e-01 | 0.417 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.031571e-01 | 0.395 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.032647e-01 | 0.518 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.402444e-01 | 0.356 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.905225e-01 | 0.537 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.801759e-01 | 0.744 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 4.831007e-01 | 0.316 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.676133e-01 | 0.330 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.022884e-01 | 0.694 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.779891e-01 | 0.556 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 2.672812e-01 | 0.573 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.710077e-01 | 0.567 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.710077e-01 | 0.567 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.429820e-01 | 0.614 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.960541e-01 | 0.402 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.022884e-01 | 0.694 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.888951e-01 | 0.410 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.732038e-01 | 0.428 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.774269e-01 | 0.751 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.032647e-01 | 0.518 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.805952e-01 | 0.743 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.520449e-01 | 0.345 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.581121e-01 | 0.446 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 2.007532e-01 | 0.697 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.443036e-01 | 0.612 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 2.443036e-01 | 0.612 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.854834e-01 | 0.544 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.244216e-01 | 0.489 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.057040e-01 | 0.687 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 3.612401e-01 | 0.442 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.466705e-01 | 0.608 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.466705e-01 | 0.608 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 3.960541e-01 | 0.402 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.960541e-01 | 0.402 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.084194e-01 | 0.511 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.084194e-01 | 0.511 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.289726e-01 | 0.368 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.600987e-01 | 0.337 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.895300e-01 | 0.310 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.083990e-01 | 0.389 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.759042e-01 | 0.322 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.138030e-01 | 0.383 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.814504e-01 | 0.317 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.692025e-01 | 0.772 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.231765e-01 | 0.491 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.016827e-01 | 0.396 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 4.289726e-01 | 0.368 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.649639e-01 | 0.333 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 2.523599e-01 | 0.598 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 2.443036e-01 | 0.612 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 2.261197e-01 | 0.646 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.672812e-01 | 0.573 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 3.960541e-01 | 0.402 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.289726e-01 | 0.368 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.886394e-01 | 0.724 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.895300e-01 | 0.310 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.895300e-01 | 0.310 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.649639e-01 | 0.333 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.931767e-01 | 0.405 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.764372e-01 | 0.424 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.764372e-01 | 0.424 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.348685e-01 | 0.475 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.045982e-01 | 0.689 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 3.612401e-01 | 0.442 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.997778e-01 | 0.699 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.895300e-01 | 0.310 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.464558e-01 | 0.350 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.430601e-01 | 0.354 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.464558e-01 | 0.350 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.316435e-01 | 0.365 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.805952e-01 | 0.743 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.288330e-01 | 0.483 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.673056e-01 | 0.573 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.600987e-01 | 0.337 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 3.691104e-01 | 0.433 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.888951e-01 | 0.410 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.732038e-01 | 0.428 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.464558e-01 | 0.350 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.375420e-01 | 0.624 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.084194e-01 | 0.511 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.289726e-01 | 0.368 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.905225e-01 | 0.537 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.514279e-01 | 0.454 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 3.691104e-01 | 0.433 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.490774e-01 | 0.457 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.910245e-01 | 0.309 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 3.288330e-01 | 0.483 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.404064e-01 | 0.356 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.982078e-01 | 0.303 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 4.031571e-01 | 0.395 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.066951e-01 | 0.295 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.084759e-01 | 0.294 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 5.084759e-01 | 0.294 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.092099e-01 | 0.293 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.144906e-01 | 0.289 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.173586e-01 | 0.286 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.173586e-01 | 0.286 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.173586e-01 | 0.286 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.173586e-01 | 0.286 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 5.173586e-01 | 0.286 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.173586e-01 | 0.286 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.173586e-01 | 0.286 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 5.173586e-01 | 0.286 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.173586e-01 | 0.286 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.173586e-01 | 0.286 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.173586e-01 | 0.286 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.173586e-01 | 0.286 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.173586e-01 | 0.286 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.175374e-01 | 0.286 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.175374e-01 | 0.286 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.181853e-01 | 0.286 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.182051e-01 | 0.285 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.182051e-01 | 0.285 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.182051e-01 | 0.285 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.182051e-01 | 0.285 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.182051e-01 | 0.285 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.182051e-01 | 0.285 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.195496e-01 | 0.284 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.195496e-01 | 0.284 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.247515e-01 | 0.280 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.287001e-01 | 0.277 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.310148e-01 | 0.275 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.351515e-01 | 0.272 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.351515e-01 | 0.272 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.351515e-01 | 0.272 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.351515e-01 | 0.272 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.351515e-01 | 0.272 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.351515e-01 | 0.272 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.355778e-01 | 0.271 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.400944e-01 | 0.268 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.436717e-01 | 0.265 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.436717e-01 | 0.265 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.436717e-01 | 0.265 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.436717e-01 | 0.265 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.436717e-01 | 0.265 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.436717e-01 | 0.265 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 5.436717e-01 | 0.265 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.447368e-01 | 0.264 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.474621e-01 | 0.262 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.474621e-01 | 0.262 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.513468e-01 | 0.259 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.513468e-01 | 0.259 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.516838e-01 | 0.258 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.516838e-01 | 0.258 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.516838e-01 | 0.258 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.516838e-01 | 0.258 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.536728e-01 | 0.257 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.538152e-01 | 0.257 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.573210e-01 | 0.254 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.573210e-01 | 0.254 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.624523e-01 | 0.250 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.624523e-01 | 0.250 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.677966e-01 | 0.246 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.677966e-01 | 0.246 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.677966e-01 | 0.246 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.685517e-01 | 0.245 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.685517e-01 | 0.245 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.685517e-01 | 0.245 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.685517e-01 | 0.245 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.685517e-01 | 0.245 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.685517e-01 | 0.245 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.685517e-01 | 0.245 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 5.685517e-01 | 0.245 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.685517e-01 | 0.245 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.685517e-01 | 0.245 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.701369e-01 | 0.244 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.701369e-01 | 0.244 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.701369e-01 | 0.244 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.701369e-01 | 0.244 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.701369e-01 | 0.244 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.701369e-01 | 0.244 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.701369e-01 | 0.244 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.734060e-01 | 0.242 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.738859e-01 | 0.241 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.827207e-01 | 0.235 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.827207e-01 | 0.235 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.827207e-01 | 0.235 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.834867e-01 | 0.234 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 5.834867e-01 | 0.234 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.920767e-01 | 0.228 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.920767e-01 | 0.228 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.920767e-01 | 0.228 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.920767e-01 | 0.228 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.920767e-01 | 0.228 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.920767e-01 | 0.228 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.920767e-01 | 0.228 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.920767e-01 | 0.228 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.920767e-01 | 0.228 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.920767e-01 | 0.228 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.920767e-01 | 0.228 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.920767e-01 | 0.228 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.920767e-01 | 0.228 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.920767e-01 | 0.228 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 5.920767e-01 | 0.228 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.920767e-01 | 0.228 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.950680e-01 | 0.225 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.950680e-01 | 0.225 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.950680e-01 | 0.225 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.979912e-01 | 0.223 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.987522e-01 | 0.223 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.987522e-01 | 0.223 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.064209e-01 | 0.217 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 6.064209e-01 | 0.217 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.071750e-01 | 0.217 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.071750e-01 | 0.217 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.071750e-01 | 0.217 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.100818e-01 | 0.215 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.135927e-01 | 0.212 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.135927e-01 | 0.212 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.135927e-01 | 0.212 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.143203e-01 | 0.212 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.143203e-01 | 0.212 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.143203e-01 | 0.212 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.143203e-01 | 0.212 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.143203e-01 | 0.212 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.143203e-01 | 0.212 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 6.143203e-01 | 0.212 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.143203e-01 | 0.212 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.143203e-01 | 0.212 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.157945e-01 | 0.211 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.157945e-01 | 0.211 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.157945e-01 | 0.211 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.190386e-01 | 0.208 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.225493e-01 | 0.206 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.231826e-01 | 0.205 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.243905e-01 | 0.205 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.257621e-01 | 0.204 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.280092e-01 | 0.202 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.287075e-01 | 0.202 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.306565e-01 | 0.200 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.326974e-01 | 0.199 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 6.353522e-01 | 0.197 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.353522e-01 | 0.197 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.353522e-01 | 0.197 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.353522e-01 | 0.197 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.353522e-01 | 0.197 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 6.353522e-01 | 0.197 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.353522e-01 | 0.197 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.353522e-01 | 0.197 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.353522e-01 | 0.197 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.353522e-01 | 0.197 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 6.353522e-01 | 0.197 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.353522e-01 | 0.197 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.353522e-01 | 0.197 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.353522e-01 | 0.197 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.357291e-01 | 0.197 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.357291e-01 | 0.197 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.357291e-01 | 0.197 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.386959e-01 | 0.195 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.386959e-01 | 0.195 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.395285e-01 | 0.194 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.420038e-01 | 0.192 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.420267e-01 | 0.192 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.455224e-01 | 0.190 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.522114e-01 | 0.186 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.531480e-01 | 0.185 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.531480e-01 | 0.185 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.531480e-01 | 0.185 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.546712e-01 | 0.184 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.551404e-01 | 0.184 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.551404e-01 | 0.184 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.552384e-01 | 0.184 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 6.552384e-01 | 0.184 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.552384e-01 | 0.184 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.552384e-01 | 0.184 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.552384e-01 | 0.184 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.552384e-01 | 0.184 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 6.552384e-01 | 0.184 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.552384e-01 | 0.184 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.552384e-01 | 0.184 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.552384e-01 | 0.184 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.552384e-01 | 0.184 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.552384e-01 | 0.184 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.552384e-01 | 0.184 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.552384e-01 | 0.184 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.552384e-01 | 0.184 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.552384e-01 | 0.184 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.554450e-01 | 0.183 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.555796e-01 | 0.183 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 6.555796e-01 | 0.183 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.555796e-01 | 0.183 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.555796e-01 | 0.183 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.555796e-01 | 0.183 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.588239e-01 | 0.181 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.588239e-01 | 0.181 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.640197e-01 | 0.178 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.645818e-01 | 0.177 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.687407e-01 | 0.175 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.687407e-01 | 0.175 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.687407e-01 | 0.175 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 6.687407e-01 | 0.175 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.687407e-01 | 0.175 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.687407e-01 | 0.175 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.728276e-01 | 0.172 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.740412e-01 | 0.171 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.740412e-01 | 0.171 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.740412e-01 | 0.171 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.740412e-01 | 0.171 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.740412e-01 | 0.171 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.740412e-01 | 0.171 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.740412e-01 | 0.171 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.740412e-01 | 0.171 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.740412e-01 | 0.171 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.740412e-01 | 0.171 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.755616e-01 | 0.170 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.784908e-01 | 0.168 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.812568e-01 | 0.167 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 6.814919e-01 | 0.167 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.814919e-01 | 0.167 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.816960e-01 | 0.166 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.829303e-01 | 0.166 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.850138e-01 | 0.164 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.889455e-01 | 0.162 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.918197e-01 | 0.160 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.918197e-01 | 0.160 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 6.918197e-01 | 0.160 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.918197e-01 | 0.160 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.918197e-01 | 0.160 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.918197e-01 | 0.160 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.918197e-01 | 0.160 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.938388e-01 | 0.159 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.938388e-01 | 0.159 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 6.938388e-01 | 0.159 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.938388e-01 | 0.159 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.996269e-01 | 0.155 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.050123e-01 | 0.152 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.057875e-01 | 0.151 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.057875e-01 | 0.151 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 7.057875e-01 | 0.151 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.073686e-01 | 0.150 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.086295e-01 | 0.150 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.086295e-01 | 0.150 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.086295e-01 | 0.150 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.086295e-01 | 0.150 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.086295e-01 | 0.150 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.086295e-01 | 0.150 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.086295e-01 | 0.150 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 7.086295e-01 | 0.150 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.086295e-01 | 0.150 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.086295e-01 | 0.150 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.086295e-01 | 0.150 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.086295e-01 | 0.150 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.091099e-01 | 0.149 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.111748e-01 | 0.148 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.146410e-01 | 0.146 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.173448e-01 | 0.144 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.215076e-01 | 0.142 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 7.240249e-01 | 0.140 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.245233e-01 | 0.140 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.245233e-01 | 0.140 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.245233e-01 | 0.140 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.245233e-01 | 0.140 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.245233e-01 | 0.140 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.245233e-01 | 0.140 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.245233e-01 | 0.140 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.245233e-01 | 0.140 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 7.245233e-01 | 0.140 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.245233e-01 | 0.140 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.245233e-01 | 0.140 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 7.245233e-01 | 0.140 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.245233e-01 | 0.140 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.256673e-01 | 0.139 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.274266e-01 | 0.138 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.285177e-01 | 0.138 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.285177e-01 | 0.138 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.285177e-01 | 0.138 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.297492e-01 | 0.137 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.297492e-01 | 0.137 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.297492e-01 | 0.137 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.297492e-01 | 0.137 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.297492e-01 | 0.137 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.326452e-01 | 0.135 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.331661e-01 | 0.135 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.331661e-01 | 0.135 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.331661e-01 | 0.135 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.331661e-01 | 0.135 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.331661e-01 | 0.135 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.331661e-01 | 0.135 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.331661e-01 | 0.135 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.350385e-01 | 0.134 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.393137e-01 | 0.131 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.393137e-01 | 0.131 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 7.393137e-01 | 0.131 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.393137e-01 | 0.131 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.395511e-01 | 0.131 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.395511e-01 | 0.131 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.420668e-01 | 0.130 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.420668e-01 | 0.130 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.420668e-01 | 0.130 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.491708e-01 | 0.125 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.497408e-01 | 0.125 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.497408e-01 | 0.125 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.497865e-01 | 0.125 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.507298e-01 | 0.125 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.508659e-01 | 0.124 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.537599e-01 | 0.123 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.537599e-01 | 0.123 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.537599e-01 | 0.123 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.537599e-01 | 0.123 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.537599e-01 | 0.123 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 7.537599e-01 | 0.123 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.537599e-01 | 0.123 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.537599e-01 | 0.123 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.537599e-01 | 0.123 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.537599e-01 | 0.123 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.566538e-01 | 0.121 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.566538e-01 | 0.121 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.575707e-01 | 0.121 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.591578e-01 | 0.120 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.598070e-01 | 0.119 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.598070e-01 | 0.119 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.598070e-01 | 0.119 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.598070e-01 | 0.119 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.598070e-01 | 0.119 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.598070e-01 | 0.119 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.598070e-01 | 0.119 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.629228e-01 | 0.118 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.631201e-01 | 0.117 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.639632e-01 | 0.117 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.640331e-01 | 0.117 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.642471e-01 | 0.117 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.664238e-01 | 0.116 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.671944e-01 | 0.115 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.671944e-01 | 0.115 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 7.671944e-01 | 0.115 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.671944e-01 | 0.115 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.671944e-01 | 0.115 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.671944e-01 | 0.115 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.671944e-01 | 0.115 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.671944e-01 | 0.115 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 7.671944e-01 | 0.115 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 7.671944e-01 | 0.115 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.671944e-01 | 0.115 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.673538e-01 | 0.115 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.673538e-01 | 0.115 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.695207e-01 | 0.114 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.695207e-01 | 0.114 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.695207e-01 | 0.114 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.696477e-01 | 0.114 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.707308e-01 | 0.113 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.753212e-01 | 0.111 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.753212e-01 | 0.111 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.782195e-01 | 0.109 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.786158e-01 | 0.109 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.788904e-01 | 0.109 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.788904e-01 | 0.109 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.788904e-01 | 0.109 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.798967e-01 | 0.108 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.798967e-01 | 0.108 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.798967e-01 | 0.108 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.798967e-01 | 0.108 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.848652e-01 | 0.105 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.879246e-01 | 0.104 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.879246e-01 | 0.104 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.879246e-01 | 0.104 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.893653e-01 | 0.103 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 7.905837e-01 | 0.102 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.919067e-01 | 0.101 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.919067e-01 | 0.101 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.919067e-01 | 0.101 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.919067e-01 | 0.101 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.919067e-01 | 0.101 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.919067e-01 | 0.101 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.919067e-01 | 0.101 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.966320e-01 | 0.099 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.966320e-01 | 0.099 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.966320e-01 | 0.099 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.976948e-01 | 0.098 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.978860e-01 | 0.098 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.979627e-01 | 0.098 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.011189e-01 | 0.096 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.011189e-01 | 0.096 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.032620e-01 | 0.095 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.032620e-01 | 0.095 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.032620e-01 | 0.095 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.032620e-01 | 0.095 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.032620e-01 | 0.095 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.032620e-01 | 0.095 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.032620e-01 | 0.095 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 8.032620e-01 | 0.095 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.032620e-01 | 0.095 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.050215e-01 | 0.094 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.067987e-01 | 0.093 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.118519e-01 | 0.091 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 8.139983e-01 | 0.089 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.139983e-01 | 0.089 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.139983e-01 | 0.089 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.139983e-01 | 0.089 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.139983e-01 | 0.089 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.139983e-01 | 0.089 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.139983e-01 | 0.089 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.139983e-01 | 0.089 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.139983e-01 | 0.089 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.139983e-01 | 0.089 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.185233e-01 | 0.087 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.204677e-01 | 0.086 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.208814e-01 | 0.086 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.208814e-01 | 0.086 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.209271e-01 | 0.086 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.222224e-01 | 0.085 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.222224e-01 | 0.085 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 8.241493e-01 | 0.084 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.241493e-01 | 0.084 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.241493e-01 | 0.084 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.241493e-01 | 0.084 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.282376e-01 | 0.082 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.282376e-01 | 0.082 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.283693e-01 | 0.082 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.334213e-01 | 0.079 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.337470e-01 | 0.079 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.337470e-01 | 0.079 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.337470e-01 | 0.079 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.337470e-01 | 0.079 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.337850e-01 | 0.079 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.339343e-01 | 0.079 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.355741e-01 | 0.078 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.355741e-01 | 0.078 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.382108e-01 | 0.077 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.425044e-01 | 0.074 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.428213e-01 | 0.074 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.428213e-01 | 0.074 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.428213e-01 | 0.074 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.428213e-01 | 0.074 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 8.428213e-01 | 0.074 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.428213e-01 | 0.074 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.428213e-01 | 0.074 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.430167e-01 | 0.074 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.432281e-01 | 0.074 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.440255e-01 | 0.074 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.489299e-01 | 0.071 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.491111e-01 | 0.071 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.491686e-01 | 0.071 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.491686e-01 | 0.071 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.491686e-01 | 0.071 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.514009e-01 | 0.070 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.514009e-01 | 0.070 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.514009e-01 | 0.070 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.514009e-01 | 0.070 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.540557e-01 | 0.069 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.555752e-01 | 0.068 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.595127e-01 | 0.066 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.595127e-01 | 0.066 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.595127e-01 | 0.066 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.595127e-01 | 0.066 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.595127e-01 | 0.066 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.595127e-01 | 0.066 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.595127e-01 | 0.066 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.595127e-01 | 0.066 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.595127e-01 | 0.066 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.597940e-01 | 0.066 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.608958e-01 | 0.065 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.617324e-01 | 0.065 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.617324e-01 | 0.065 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.620941e-01 | 0.064 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 8.635327e-01 | 0.064 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.635948e-01 | 0.064 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.646125e-01 | 0.063 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.648451e-01 | 0.063 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.671821e-01 | 0.062 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.671821e-01 | 0.062 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.671821e-01 | 0.062 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.671821e-01 | 0.062 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.671821e-01 | 0.062 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.699669e-01 | 0.060 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.699669e-01 | 0.060 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.724780e-01 | 0.059 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.731560e-01 | 0.059 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.733309e-01 | 0.059 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.744332e-01 | 0.058 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.744332e-01 | 0.058 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.744332e-01 | 0.058 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 8.744332e-01 | 0.058 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.748048e-01 | 0.058 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.787880e-01 | 0.056 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 8.787880e-01 | 0.056 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.811700e-01 | 0.055 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.812890e-01 | 0.055 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 8.812890e-01 | 0.055 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.812890e-01 | 0.055 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.816220e-01 | 0.055 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.821657e-01 | 0.054 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.830460e-01 | 0.054 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.840041e-01 | 0.054 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.840273e-01 | 0.054 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.877707e-01 | 0.052 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.877707e-01 | 0.052 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 8.877707e-01 | 0.052 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.877707e-01 | 0.052 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.877707e-01 | 0.052 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.888594e-01 | 0.051 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.890563e-01 | 0.051 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.890563e-01 | 0.051 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.890563e-01 | 0.051 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.894466e-01 | 0.051 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.903885e-01 | 0.050 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.919943e-01 | 0.050 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.925959e-01 | 0.049 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.938990e-01 | 0.049 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.938990e-01 | 0.049 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.944595e-01 | 0.048 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.985125e-01 | 0.046 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.990351e-01 | 0.046 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.996930e-01 | 0.046 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.996930e-01 | 0.046 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.996930e-01 | 0.046 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.996930e-01 | 0.046 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.996930e-01 | 0.046 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.040624e-01 | 0.044 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.044152e-01 | 0.044 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.051709e-01 | 0.043 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.051709e-01 | 0.043 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.051709e-01 | 0.043 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.051709e-01 | 0.043 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.051709e-01 | 0.043 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.051709e-01 | 0.043 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.051709e-01 | 0.043 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.099789e-01 | 0.041 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.103499e-01 | 0.041 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.103499e-01 | 0.041 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.103499e-01 | 0.041 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.103499e-01 | 0.041 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.103499e-01 | 0.041 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.109899e-01 | 0.040 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.112973e-01 | 0.040 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.136875e-01 | 0.039 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.150461e-01 | 0.039 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.150461e-01 | 0.039 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.152123e-01 | 0.038 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.152464e-01 | 0.038 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.152464e-01 | 0.038 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.152464e-01 | 0.038 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.152464e-01 | 0.038 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.152464e-01 | 0.038 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.152464e-01 | 0.038 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.164519e-01 | 0.038 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.198758e-01 | 0.036 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.198758e-01 | 0.036 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.209805e-01 | 0.036 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.225319e-01 | 0.035 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.225603e-01 | 0.035 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.242525e-01 | 0.034 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.242525e-01 | 0.034 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.242525e-01 | 0.034 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.242525e-01 | 0.034 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.245898e-01 | 0.034 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.260053e-01 | 0.033 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.275461e-01 | 0.033 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.283904e-01 | 0.032 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.283904e-01 | 0.032 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.303957e-01 | 0.031 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.323026e-01 | 0.030 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.323026e-01 | 0.030 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.324659e-01 | 0.030 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.354924e-01 | 0.029 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.354924e-01 | 0.029 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.354924e-01 | 0.029 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.354924e-01 | 0.029 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.360012e-01 | 0.029 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.360012e-01 | 0.029 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.360012e-01 | 0.029 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.360012e-01 | 0.029 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.383900e-01 | 0.028 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.394979e-01 | 0.027 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.394979e-01 | 0.027 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.428038e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.428038e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.431567e-01 | 0.025 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.438188e-01 | 0.025 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.438188e-01 | 0.025 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.439356e-01 | 0.025 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.459293e-01 | 0.024 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.463595e-01 | 0.024 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.464189e-01 | 0.024 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.488841e-01 | 0.023 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.488841e-01 | 0.023 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.497345e-01 | 0.022 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.511162e-01 | 0.022 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.516776e-01 | 0.022 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.516776e-01 | 0.022 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.533409e-01 | 0.021 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.533409e-01 | 0.021 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.548128e-01 | 0.020 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.549991e-01 | 0.020 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.560532e-01 | 0.020 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.568155e-01 | 0.019 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.589099e-01 | 0.018 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.591760e-01 | 0.018 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.591760e-01 | 0.018 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.613087e-01 | 0.017 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.635174e-01 | 0.016 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.639203e-01 | 0.016 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.650354e-01 | 0.015 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.657896e-01 | 0.015 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.679618e-01 | 0.014 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.691801e-01 | 0.014 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.697346e-01 | 0.013 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.724586e-01 | 0.012 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.724586e-01 | 0.012 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.724586e-01 | 0.012 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.747404e-01 | 0.011 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.747404e-01 | 0.011 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.767348e-01 | 0.010 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.767348e-01 | 0.010 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.774453e-01 | 0.010 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.780073e-01 | 0.010 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.781185e-01 | 0.010 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.792103e-01 | 0.009 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.792103e-01 | 0.009 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.801230e-01 | 0.009 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.803476e-01 | 0.009 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.813095e-01 | 0.008 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.822157e-01 | 0.008 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.827999e-01 | 0.008 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.833558e-01 | 0.007 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.843082e-01 | 0.007 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.843864e-01 | 0.007 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.851669e-01 | 0.006 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.857396e-01 | 0.006 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.858276e-01 | 0.006 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.859786e-01 | 0.006 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.860347e-01 | 0.006 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.874714e-01 | 0.005 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.877554e-01 | 0.005 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.879838e-01 | 0.005 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.881571e-01 | 0.005 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.894182e-01 | 0.005 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.894182e-01 | 0.005 | 0 | 0 |
| Translation | R-HSA-72766 | 9.896043e-01 | 0.005 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.897583e-01 | 0.004 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.905451e-01 | 0.004 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.905451e-01 | 0.004 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.910627e-01 | 0.004 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.913092e-01 | 0.004 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.917160e-01 | 0.004 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.920147e-01 | 0.003 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.920147e-01 | 0.003 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.925031e-01 | 0.003 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.925165e-01 | 0.003 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.939767e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.941459e-01 | 0.003 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.941459e-01 | 0.003 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.942955e-01 | 0.002 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.943046e-01 | 0.002 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.951903e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.951903e-01 | 0.002 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.962200e-01 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.968457e-01 | 0.001 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.969359e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.969623e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.972405e-01 | 0.001 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.972408e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.975546e-01 | 0.001 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.976205e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.980484e-01 | 0.001 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.983029e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.983295e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.984121e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.984465e-01 | 0.001 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.985281e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.985783e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.985783e-01 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.986108e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.987348e-01 | 0.001 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.987573e-01 | 0.001 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.988899e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.990084e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.990178e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.992324e-01 | 0.000 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.992977e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.993674e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.995502e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.996412e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.997081e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.997206e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.998261e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.998876e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999084e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999221e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999304e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999566e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999675e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999702e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999881e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999887e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999893e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999953e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999993e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999995e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999998e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.220446e-16 | 15.654 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.220446e-16 | 15.654 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.107026e-15 | 14.292 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.385381e-14 | 13.358 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.672440e-12 | 11.777 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.847189e-12 | 11.733 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.375766e-12 | 11.624 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.671308e-12 | 11.573 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.418865e-11 | 10.466 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.762657e-11 | 10.425 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.627949e-10 | 9.788 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.868856e-10 | 9.412 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.150819e-10 | 9.288 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.800165e-10 | 9.056 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.111165e-09 | 8.954 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.137741e-09 | 8.944 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.285570e-09 | 8.891 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.651967e-09 | 8.782 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.731553e-09 | 8.762 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.446366e-09 | 8.611 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.446366e-09 | 8.611 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.134010e-09 | 8.290 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.725709e-09 | 8.242 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.909258e-09 | 8.228 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.350537e-09 | 8.197 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.481984e-09 | 8.126 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.244547e-09 | 8.084 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.058033e-09 | 8.043 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 8.980303e-09 | 8.047 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 9.700306e-09 | 8.013 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.921468e-09 | 8.003 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.127255e-08 | 7.948 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.372540e-08 | 7.862 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.661075e-08 | 7.780 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.866176e-08 | 7.729 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.278085e-08 | 7.642 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.278085e-08 | 7.642 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.097649e-08 | 7.387 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.097649e-08 | 7.387 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.022761e-08 | 7.395 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.845796e-08 | 7.315 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.877261e-08 | 7.231 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.767681e-08 | 7.170 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.409578e-08 | 7.130 | 1 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.373849e-08 | 7.028 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.596086e-08 | 7.018 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.122599e-07 | 6.950 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.141622e-07 | 6.942 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.228883e-07 | 6.910 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.369937e-07 | 6.863 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.592267e-07 | 6.798 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.643678e-07 | 6.784 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.882246e-07 | 6.725 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.419939e-07 | 6.616 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.369234e-07 | 6.625 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.652973e-07 | 6.576 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.688632e-07 | 6.570 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.168930e-07 | 6.499 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.506606e-07 | 6.455 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.005154e-07 | 6.397 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.557951e-07 | 6.341 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.614287e-07 | 6.336 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.282214e-07 | 6.277 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.530642e-07 | 6.257 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.802885e-07 | 6.236 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.802885e-07 | 6.236 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.390279e-07 | 6.194 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.076523e-07 | 6.150 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.038371e-07 | 6.153 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.182158e-07 | 6.144 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.346279e-07 | 6.134 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.966617e-07 | 6.099 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.156690e-06 | 5.937 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.238793e-06 | 5.907 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.401445e-06 | 5.853 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.548881e-06 | 5.810 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.560523e-06 | 5.807 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.575028e-06 | 5.803 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.032050e-06 | 5.692 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.070073e-06 | 5.684 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.126136e-06 | 5.672 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.130209e-06 | 5.672 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.299641e-06 | 5.638 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.333271e-06 | 5.632 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.937452e-06 | 5.532 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.957815e-06 | 5.529 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.707423e-06 | 5.431 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.707423e-06 | 5.431 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.416724e-06 | 5.355 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.416724e-06 | 5.355 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.540353e-06 | 5.343 | 1 | 1 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.525288e-06 | 5.258 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.625543e-06 | 5.250 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.984842e-06 | 5.223 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.000871e-06 | 5.222 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.582435e-06 | 5.182 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.566325e-06 | 5.183 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.053628e-06 | 5.152 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.115328e-06 | 5.148 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.094379e-06 | 5.041 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.094379e-06 | 5.041 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.810991e-06 | 5.055 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.012619e-06 | 5.045 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.420796e-06 | 5.026 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.626691e-06 | 5.017 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.433042e-05 | 4.844 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.783384e-05 | 4.749 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.973509e-05 | 4.705 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.015344e-05 | 4.696 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.164418e-05 | 4.665 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.298361e-05 | 4.639 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.326220e-05 | 4.633 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.397486e-05 | 4.620 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.397486e-05 | 4.620 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.453908e-05 | 4.610 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.529205e-05 | 4.597 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.543711e-05 | 4.595 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.816042e-05 | 4.550 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.940602e-05 | 4.532 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.209128e-05 | 4.494 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.250703e-05 | 4.488 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.278678e-05 | 4.484 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.376721e-05 | 4.472 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.580240e-05 | 4.446 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.733333e-05 | 4.428 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.876146e-05 | 4.412 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.059412e-05 | 4.392 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.146061e-05 | 4.382 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.172756e-05 | 4.380 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.418683e-05 | 4.355 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.451886e-05 | 4.351 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.792215e-05 | 4.319 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.959780e-05 | 4.305 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.819516e-05 | 4.235 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.618703e-05 | 4.250 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.978263e-05 | 4.223 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.334485e-05 | 4.198 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.339343e-05 | 4.198 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.394872e-05 | 4.194 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.661070e-05 | 4.176 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.729555e-05 | 4.172 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.729555e-05 | 4.172 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 8.300744e-05 | 4.081 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.122394e-05 | 4.040 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.437841e-05 | 4.074 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.944701e-05 | 4.048 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 9.626230e-05 | 4.017 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.751238e-05 | 4.011 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.054671e-04 | 3.977 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.054671e-04 | 3.977 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.119959e-04 | 3.951 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.208779e-04 | 3.918 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.208457e-04 | 3.918 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.211195e-04 | 3.917 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.259209e-04 | 3.900 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.211195e-04 | 3.917 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.283645e-04 | 3.892 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.208457e-04 | 3.918 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.299338e-04 | 3.886 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.454064e-04 | 3.837 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.486168e-04 | 3.828 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.519540e-04 | 3.818 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.519540e-04 | 3.818 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.646695e-04 | 3.783 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.734099e-04 | 3.761 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.760222e-04 | 3.754 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.765351e-04 | 3.753 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.961041e-04 | 3.708 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.005251e-04 | 3.698 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.005251e-04 | 3.698 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.071206e-04 | 3.684 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.071206e-04 | 3.684 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.091488e-04 | 3.680 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.128429e-04 | 3.672 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.392253e-04 | 3.621 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.486317e-04 | 3.604 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.559312e-04 | 3.592 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.706584e-04 | 3.568 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.712462e-04 | 3.567 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.712462e-04 | 3.567 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.982622e-04 | 3.525 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.024707e-04 | 3.519 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.073872e-04 | 3.512 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.161479e-04 | 3.500 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.226195e-04 | 3.491 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.316496e-04 | 3.479 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.362040e-04 | 3.473 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.436480e-04 | 3.464 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.560874e-04 | 3.448 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.586260e-04 | 3.445 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.586923e-04 | 3.445 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.959717e-04 | 3.402 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.044156e-04 | 3.393 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.883903e-04 | 3.411 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.544835e-04 | 3.342 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.544835e-04 | 3.342 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.683834e-04 | 3.329 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.683834e-04 | 3.329 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.876402e-04 | 3.312 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.592558e-04 | 3.252 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.647653e-04 | 3.248 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.857585e-04 | 3.232 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.165636e-04 | 3.210 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.345825e-04 | 3.198 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.345825e-04 | 3.198 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.345825e-04 | 3.198 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.345825e-04 | 3.198 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.778079e-04 | 3.169 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.259512e-04 | 3.139 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.546845e-04 | 3.184 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.535091e-04 | 3.185 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.668587e-04 | 3.176 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 6.815966e-04 | 3.166 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.396438e-04 | 3.194 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.385489e-04 | 3.195 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.644857e-04 | 3.178 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.186611e-04 | 3.143 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.259512e-04 | 3.139 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.713653e-04 | 3.113 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.716956e-04 | 3.113 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.779960e-04 | 3.109 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.955278e-04 | 3.099 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.541771e-04 | 3.068 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.541771e-04 | 3.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.541771e-04 | 3.068 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.541771e-04 | 3.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.541771e-04 | 3.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.541771e-04 | 3.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.541771e-04 | 3.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.541771e-04 | 3.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.541771e-04 | 3.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.541771e-04 | 3.068 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.541771e-04 | 3.068 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.556509e-04 | 3.068 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 8.803491e-04 | 3.055 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.803491e-04 | 3.055 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.841071e-04 | 3.053 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 9.092104e-04 | 3.041 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.101372e-04 | 3.041 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.101372e-04 | 3.041 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.070464e-03 | 2.970 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 9.309964e-04 | 3.031 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.861120e-04 | 3.006 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 9.309964e-04 | 3.031 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 9.309964e-04 | 3.031 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.070464e-03 | 2.970 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.001383e-03 | 2.999 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.011928e-03 | 2.995 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.178618e-04 | 3.037 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.089557e-03 | 2.963 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.101901e-03 | 2.958 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.101901e-03 | 2.958 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.103455e-03 | 2.957 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.144107e-03 | 2.942 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.215299e-03 | 2.915 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.234272e-03 | 2.909 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.234272e-03 | 2.909 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.265858e-03 | 2.898 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.281696e-03 | 2.892 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.284311e-03 | 2.891 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.297020e-03 | 2.887 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.298678e-03 | 2.886 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.352201e-03 | 2.869 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.380886e-03 | 2.860 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.403464e-03 | 2.853 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.430659e-03 | 2.844 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.465986e-03 | 2.834 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.504903e-03 | 2.822 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.541747e-03 | 2.812 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.578565e-03 | 2.802 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.623523e-03 | 2.790 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.682698e-03 | 2.774 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.682698e-03 | 2.774 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.704648e-03 | 2.768 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.736817e-03 | 2.760 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.902996e-03 | 2.721 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.902996e-03 | 2.721 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.758136e-03 | 2.755 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.864817e-03 | 2.729 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.758136e-03 | 2.755 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.985789e-03 | 2.702 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.801170e-03 | 2.744 | 0 | 0 |
| Translation | R-HSA-72766 | 2.088551e-03 | 2.680 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.021104e-03 | 2.694 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.107074e-03 | 2.676 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.154635e-03 | 2.667 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.159146e-03 | 2.666 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.260535e-03 | 2.646 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.260535e-03 | 2.646 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.301121e-03 | 2.638 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.306799e-03 | 2.637 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.330302e-03 | 2.633 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.342684e-03 | 2.630 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.415980e-03 | 2.617 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.449530e-03 | 2.611 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.449530e-03 | 2.611 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.496316e-03 | 2.603 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.500468e-03 | 2.602 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.529596e-03 | 2.597 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.529596e-03 | 2.597 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.619441e-03 | 2.582 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.619441e-03 | 2.582 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.785082e-03 | 2.555 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.832164e-03 | 2.548 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.832164e-03 | 2.548 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.868241e-03 | 2.542 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.889115e-03 | 2.539 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.938985e-03 | 2.532 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.952939e-03 | 2.530 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.975842e-03 | 2.526 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.013974e-03 | 2.521 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.013974e-03 | 2.521 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.038553e-03 | 2.517 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.100041e-03 | 2.509 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.135771e-03 | 2.504 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.349587e-03 | 2.475 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.417626e-03 | 2.466 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.417626e-03 | 2.466 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.623158e-03 | 2.441 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.623158e-03 | 2.441 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 3.681003e-03 | 2.434 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.755378e-03 | 2.425 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.941563e-03 | 2.404 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.952761e-03 | 2.403 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.077693e-03 | 2.390 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.096248e-03 | 2.388 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.466388e-03 | 2.350 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.466388e-03 | 2.350 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.466388e-03 | 2.350 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.466388e-03 | 2.350 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.490549e-03 | 2.348 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.924904e-03 | 2.308 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.775776e-03 | 2.321 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.508139e-03 | 2.259 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.833576e-03 | 2.316 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.489563e-03 | 2.260 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.878073e-03 | 2.312 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.969865e-03 | 2.304 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.033614e-03 | 2.298 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.439929e-03 | 2.264 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.439929e-03 | 2.264 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.888977e-03 | 2.311 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.742694e-03 | 2.241 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 5.033614e-03 | 2.298 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.689172e-03 | 2.329 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.616414e-03 | 2.251 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.563140e-03 | 2.255 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.190221e-03 | 2.285 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.756192e-03 | 2.240 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.773576e-03 | 2.239 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.942666e-03 | 2.226 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.044160e-03 | 2.219 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.044160e-03 | 2.219 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.044160e-03 | 2.219 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.294751e-03 | 2.201 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.294751e-03 | 2.201 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.515167e-03 | 2.186 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.578235e-03 | 2.182 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.661613e-03 | 2.176 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.661613e-03 | 2.176 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.661613e-03 | 2.176 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.685058e-03 | 2.175 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.685058e-03 | 2.175 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.697843e-03 | 2.174 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.734369e-03 | 2.172 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.793622e-03 | 2.168 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 6.793622e-03 | 2.168 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.810086e-03 | 2.167 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.810086e-03 | 2.167 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.810086e-03 | 2.167 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.810086e-03 | 2.167 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.072797e-03 | 2.150 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.648923e-03 | 2.116 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.648923e-03 | 2.116 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.949402e-03 | 2.100 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.070676e-03 | 2.093 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.129280e-03 | 2.090 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.129280e-03 | 2.090 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.178439e-03 | 2.087 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 8.312501e-03 | 2.080 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.374033e-03 | 2.077 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.596935e-03 | 2.066 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.596935e-03 | 2.066 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.605602e-03 | 2.065 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.987931e-03 | 2.046 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.991985e-03 | 2.046 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 9.001502e-03 | 2.046 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.528586e-03 | 2.021 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.577133e-03 | 2.019 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.664534e-03 | 2.015 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 9.915326e-03 | 2.004 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 9.915326e-03 | 2.004 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.976779e-03 | 2.001 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.008621e-02 | 1.996 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.008621e-02 | 1.996 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.065534e-02 | 1.972 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.071421e-02 | 1.970 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.079699e-02 | 1.967 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.103122e-02 | 1.957 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.103122e-02 | 1.957 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.105519e-02 | 1.956 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.105519e-02 | 1.956 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.121386e-02 | 1.950 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.121386e-02 | 1.950 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.132291e-02 | 1.946 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.153123e-02 | 1.938 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.165561e-02 | 1.933 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.181212e-02 | 1.928 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.181212e-02 | 1.928 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.181212e-02 | 1.928 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.181212e-02 | 1.928 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.541918e-02 | 1.812 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.541918e-02 | 1.812 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.541918e-02 | 1.812 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 1.466951e-02 | 1.834 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.481806e-02 | 1.829 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.481806e-02 | 1.829 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.481806e-02 | 1.829 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.587801e-02 | 1.799 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.233709e-02 | 1.909 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.447886e-02 | 1.839 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.317051e-02 | 1.880 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.587801e-02 | 1.799 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.511196e-02 | 1.821 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.511196e-02 | 1.821 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.481806e-02 | 1.829 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.256612e-02 | 1.901 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.353416e-02 | 1.869 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.583809e-02 | 1.800 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.541122e-02 | 1.812 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.414834e-02 | 1.849 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.481806e-02 | 1.829 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.208197e-02 | 1.918 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.238720e-02 | 1.907 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.575926e-02 | 1.802 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.234669e-02 | 1.908 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.566768e-02 | 1.805 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.617099e-02 | 1.791 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.617099e-02 | 1.791 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.617099e-02 | 1.791 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.629277e-02 | 1.788 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.663916e-02 | 1.779 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.683088e-02 | 1.774 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.697559e-02 | 1.770 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.713365e-02 | 1.766 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.717906e-02 | 1.765 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.717906e-02 | 1.765 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.728614e-02 | 1.762 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.728614e-02 | 1.762 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.740216e-02 | 1.759 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.740216e-02 | 1.759 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.792515e-02 | 1.747 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.841319e-02 | 1.735 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.841319e-02 | 1.735 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.841319e-02 | 1.735 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.841319e-02 | 1.735 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.841319e-02 | 1.735 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.841319e-02 | 1.735 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.848656e-02 | 1.733 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.848656e-02 | 1.733 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.872151e-02 | 1.728 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.919631e-02 | 1.717 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.925635e-02 | 1.715 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.925635e-02 | 1.715 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.943011e-02 | 1.712 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.943011e-02 | 1.712 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.943011e-02 | 1.712 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.993868e-02 | 1.700 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.003069e-02 | 1.698 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.081939e-02 | 1.682 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.115083e-02 | 1.675 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.115083e-02 | 1.675 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.139292e-02 | 1.670 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.139292e-02 | 1.670 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.146116e-02 | 1.668 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.209220e-02 | 1.656 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.247511e-02 | 1.648 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.258543e-02 | 1.646 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.283522e-02 | 1.641 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.323258e-02 | 1.634 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.353055e-02 | 1.628 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.383101e-02 | 1.623 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.472790e-02 | 1.607 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.472790e-02 | 1.607 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.472790e-02 | 1.607 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.472790e-02 | 1.607 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.580513e-02 | 1.588 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.608576e-02 | 1.584 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 2.608576e-02 | 1.584 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 2.608576e-02 | 1.584 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.608576e-02 | 1.584 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.608576e-02 | 1.584 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.630037e-02 | 1.580 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.631865e-02 | 1.580 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.631865e-02 | 1.580 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.631865e-02 | 1.580 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.631865e-02 | 1.580 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.631865e-02 | 1.580 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.751875e-02 | 1.560 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.776377e-02 | 1.557 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.776377e-02 | 1.557 | 0 | 0 |
| RSK activation | R-HSA-444257 | 2.795348e-02 | 1.554 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.795348e-02 | 1.554 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.795348e-02 | 1.554 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.816444e-02 | 1.550 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.907631e-02 | 1.536 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.916103e-02 | 1.535 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.938023e-02 | 1.532 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.953561e-02 | 1.530 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.010652e-02 | 1.521 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.042010e-02 | 1.517 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.042010e-02 | 1.517 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.042010e-02 | 1.517 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.073084e-02 | 1.512 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.073084e-02 | 1.512 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.073084e-02 | 1.512 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.206009e-02 | 1.494 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 3.231193e-02 | 1.491 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.231193e-02 | 1.491 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.232441e-02 | 1.490 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.255934e-02 | 1.487 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.255934e-02 | 1.487 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.281499e-02 | 1.484 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.334721e-02 | 1.477 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.334721e-02 | 1.477 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.396197e-02 | 1.469 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.496193e-02 | 1.456 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.874817e-02 | 1.412 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.055136e-02 | 1.296 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.662700e-02 | 1.331 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 3.995205e-02 | 1.398 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 4.828477e-02 | 1.316 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.828477e-02 | 1.316 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.828477e-02 | 1.316 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.828477e-02 | 1.316 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.961039e-02 | 1.402 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 3.961039e-02 | 1.402 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.961039e-02 | 1.402 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.657270e-02 | 1.332 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.763264e-02 | 1.424 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.677825e-02 | 1.434 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.195275e-02 | 1.284 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.663169e-02 | 1.436 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.567333e-02 | 1.340 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.126493e-02 | 1.290 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.660294e-02 | 1.436 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.995205e-02 | 1.398 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.055136e-02 | 1.296 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 4.828477e-02 | 1.316 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.660294e-02 | 1.436 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.631427e-02 | 1.440 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.663169e-02 | 1.436 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.995205e-02 | 1.398 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.677825e-02 | 1.434 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.567333e-02 | 1.340 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.961039e-02 | 1.402 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.594662e-02 | 1.338 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.657270e-02 | 1.332 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.106121e-02 | 1.387 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.062306e-02 | 1.296 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.399574e-02 | 1.268 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.995205e-02 | 1.398 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 3.995205e-02 | 1.398 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 5.424793e-02 | 1.266 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.349832e-02 | 1.362 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.797083e-02 | 1.319 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.763660e-02 | 1.424 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.860540e-02 | 1.413 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.938767e-02 | 1.306 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.591775e-02 | 1.252 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.591775e-02 | 1.252 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.691812e-02 | 1.245 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.699136e-02 | 1.244 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.714442e-02 | 1.243 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.752578e-02 | 1.240 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.756781e-02 | 1.240 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.762976e-02 | 1.239 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.802282e-02 | 1.236 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.802282e-02 | 1.236 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.938681e-02 | 1.226 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.171251e-02 | 1.210 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.182280e-02 | 1.209 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.236873e-02 | 1.205 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.264423e-02 | 1.203 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.334977e-02 | 1.198 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 6.446602e-02 | 1.191 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 6.446602e-02 | 1.191 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.446602e-02 | 1.191 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.447331e-02 | 1.191 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.447331e-02 | 1.191 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.447331e-02 | 1.191 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.447331e-02 | 1.191 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.447331e-02 | 1.191 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 6.447331e-02 | 1.191 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.447331e-02 | 1.191 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.449047e-02 | 1.191 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.485251e-02 | 1.188 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.688726e-02 | 1.175 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.689755e-02 | 1.175 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.780124e-02 | 1.169 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.780124e-02 | 1.169 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.780124e-02 | 1.169 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.780124e-02 | 1.169 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.780124e-02 | 1.169 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.780124e-02 | 1.169 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.780124e-02 | 1.169 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.897446e-02 | 1.161 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.996657e-02 | 1.155 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.063472e-02 | 1.151 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.063472e-02 | 1.151 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.063472e-02 | 1.151 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.076627e-02 | 1.150 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.080289e-02 | 1.150 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.086342e-02 | 1.150 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.131786e-02 | 1.147 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.176413e-02 | 1.144 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.176413e-02 | 1.144 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.180023e-02 | 1.144 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.264418e-02 | 1.139 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.431442e-02 | 1.129 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.442673e-02 | 1.128 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.503853e-02 | 1.125 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.526695e-02 | 1.123 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.556629e-02 | 1.122 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.897541e-02 | 1.103 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.897541e-02 | 1.103 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 7.897541e-02 | 1.103 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.897541e-02 | 1.103 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.137967e-02 | 1.089 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.316026e-02 | 1.080 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 8.481449e-02 | 1.072 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.481449e-02 | 1.072 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.481449e-02 | 1.072 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 8.481449e-02 | 1.072 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.481449e-02 | 1.072 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 8.530315e-02 | 1.069 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 8.530315e-02 | 1.069 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 8.530315e-02 | 1.069 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 8.530315e-02 | 1.069 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 8.530315e-02 | 1.069 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.824528e-02 | 1.054 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.064422e-02 | 1.043 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 9.069396e-02 | 1.042 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 9.107157e-02 | 1.041 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.122602e-02 | 1.040 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.188222e-02 | 1.037 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.231006e-02 | 1.035 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.231006e-02 | 1.035 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.352913e-02 | 1.029 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 9.432331e-02 | 1.025 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 9.432331e-02 | 1.025 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 9.432331e-02 | 1.025 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 9.519446e-02 | 1.021 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.519446e-02 | 1.021 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.634707e-02 | 1.016 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 9.761766e-02 | 1.010 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 9.761766e-02 | 1.010 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.761766e-02 | 1.010 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 9.761766e-02 | 1.010 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 9.761766e-02 | 1.010 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.761766e-02 | 1.010 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 9.761766e-02 | 1.010 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 9.761766e-02 | 1.010 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 9.761766e-02 | 1.010 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 9.761766e-02 | 1.010 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.794185e-02 | 1.009 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.001086e-01 | 1.000 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.005886e-01 | 0.997 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.005886e-01 | 0.997 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.005886e-01 | 0.997 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.005886e-01 | 0.997 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.026841e-01 | 0.988 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.026841e-01 | 0.988 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.026841e-01 | 0.988 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.030100e-01 | 0.987 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 1.034093e-01 | 0.985 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.040626e-01 | 0.983 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.049477e-01 | 0.979 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 1.056066e-01 | 0.976 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 1.056066e-01 | 0.976 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.056066e-01 | 0.976 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.056066e-01 | 0.976 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.056066e-01 | 0.976 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 1.059518e-01 | 0.975 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.110303e-01 | 0.955 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.110303e-01 | 0.955 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.110303e-01 | 0.955 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.156829e-01 | 0.937 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.165763e-01 | 0.933 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.165763e-01 | 0.933 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.165763e-01 | 0.933 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 1.179140e-01 | 0.928 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.179140e-01 | 0.928 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.183734e-01 | 0.927 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.191028e-01 | 0.924 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.198239e-01 | 0.921 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.201128e-01 | 0.920 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.204281e-01 | 0.919 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.208101e-01 | 0.918 | 0 | 0 |
| Defective ACTH causes obesity and POMCD | R-HSA-5579031 | 1.857113e-01 | 0.731 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.857113e-01 | 0.731 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.857113e-01 | 0.731 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.857113e-01 | 0.731 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.857113e-01 | 0.731 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.272678e-01 | 0.895 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.272678e-01 | 0.895 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.272678e-01 | 0.895 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.624131e-01 | 0.789 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.624131e-01 | 0.789 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.624131e-01 | 0.789 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.624131e-01 | 0.789 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.275871e-01 | 0.894 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.275871e-01 | 0.894 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 1.275871e-01 | 0.894 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.990161e-01 | 0.701 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.990161e-01 | 0.701 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.510246e-01 | 0.821 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.510246e-01 | 0.821 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.510246e-01 | 0.821 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.364580e-01 | 0.626 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.364580e-01 | 0.626 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.341346e-01 | 0.872 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 1.526920e-01 | 0.816 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.526920e-01 | 0.816 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.526920e-01 | 0.816 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.013841e-01 | 0.696 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.013841e-01 | 0.696 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.013841e-01 | 0.696 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.325844e-01 | 0.878 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.278746e-01 | 0.642 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.278746e-01 | 0.642 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.480268e-01 | 0.830 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.279332e-01 | 0.893 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.924099e-01 | 0.716 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.133651e-01 | 0.671 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.133651e-01 | 0.671 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.549811e-01 | 0.810 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.984495e-01 | 0.702 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.349120e-01 | 0.629 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.365210e-01 | 0.865 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.696502e-01 | 0.770 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.959912e-01 | 0.708 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.809881e-01 | 0.742 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.809881e-01 | 0.742 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.619068e-01 | 0.791 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.046351e-01 | 0.689 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.169113e-01 | 0.664 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.422816e-01 | 0.847 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.155938e-01 | 0.666 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.258764e-01 | 0.900 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.348857e-01 | 0.629 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.997201e-01 | 0.700 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.678154e-01 | 0.775 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.013841e-01 | 0.696 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.693745e-01 | 0.771 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.951548e-01 | 0.710 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.951548e-01 | 0.710 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.318794e-01 | 0.635 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.341346e-01 | 0.872 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.155938e-01 | 0.666 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.277066e-01 | 0.643 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.275871e-01 | 0.894 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.164267e-01 | 0.665 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.164267e-01 | 0.665 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.349120e-01 | 0.629 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.275871e-01 | 0.894 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 2.278746e-01 | 0.642 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.624965e-01 | 0.789 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.169113e-01 | 0.664 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.999650e-01 | 0.699 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.378301e-01 | 0.861 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.990161e-01 | 0.701 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 1.924099e-01 | 0.716 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.810167e-01 | 0.742 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.128182e-01 | 0.672 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.128182e-01 | 0.672 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.146799e-01 | 0.668 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.146799e-01 | 0.668 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.406674e-01 | 0.619 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.485280e-01 | 0.828 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.133651e-01 | 0.671 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.624131e-01 | 0.789 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.406674e-01 | 0.619 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.445280e-01 | 0.840 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.990161e-01 | 0.701 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.348857e-01 | 0.629 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.485341e-01 | 0.605 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.415154e-01 | 0.849 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 2.348857e-01 | 0.629 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.480268e-01 | 0.830 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.402168e-01 | 0.853 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.942479e-01 | 0.712 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.156350e-01 | 0.666 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.133651e-01 | 0.671 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.318794e-01 | 0.635 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.710218e-01 | 0.767 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.223501e-01 | 0.653 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.549811e-01 | 0.810 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.857113e-01 | 0.731 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.857113e-01 | 0.731 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.272678e-01 | 0.895 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.275871e-01 | 0.894 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 1.990161e-01 | 0.701 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.411563e-01 | 0.850 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.133651e-01 | 0.671 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.984495e-01 | 0.702 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.325844e-01 | 0.878 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.286014e-01 | 0.891 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.422846e-01 | 0.847 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.253690e-01 | 0.902 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.984495e-01 | 0.702 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 1.539741e-01 | 0.813 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.523126e-01 | 0.817 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.365651e-01 | 0.626 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.314832e-01 | 0.881 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.364580e-01 | 0.626 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 1.756967e-01 | 0.755 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 1.473968e-01 | 0.832 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.529492e-01 | 0.815 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.000748e-01 | 0.699 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 2.359950e-01 | 0.627 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.485341e-01 | 0.605 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.274615e-01 | 0.643 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.591096e-01 | 0.798 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.641896e-01 | 0.785 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.780337e-01 | 0.749 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.325844e-01 | 0.878 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.711228e-01 | 0.767 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.476038e-01 | 0.831 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.968716e-01 | 0.706 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.278678e-01 | 0.893 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 1.510246e-01 | 0.821 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.364580e-01 | 0.626 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.648689e-01 | 0.783 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.258764e-01 | 0.900 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.364580e-01 | 0.626 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.155938e-01 | 0.666 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.903010e-01 | 0.721 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.985377e-01 | 0.702 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.959912e-01 | 0.708 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 1.624131e-01 | 0.789 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.721509e-01 | 0.764 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.480268e-01 | 0.830 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.485341e-01 | 0.605 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.843003e-01 | 0.734 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.452986e-01 | 0.838 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.985377e-01 | 0.702 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.526920e-01 | 0.816 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.286014e-01 | 0.891 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.325844e-01 | 0.878 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 2.424368e-01 | 0.615 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.624131e-01 | 0.789 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.499187e-01 | 0.602 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.502677e-01 | 0.602 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.527675e-01 | 0.597 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.537629e-01 | 0.596 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.537629e-01 | 0.596 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.537629e-01 | 0.596 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.549663e-01 | 0.594 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 2.549663e-01 | 0.594 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.553373e-01 | 0.593 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.569473e-01 | 0.590 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.569473e-01 | 0.590 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.569473e-01 | 0.590 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.569473e-01 | 0.590 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.569473e-01 | 0.590 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.569473e-01 | 0.590 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.569473e-01 | 0.590 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.649619e-01 | 0.577 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.652096e-01 | 0.576 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.652096e-01 | 0.576 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.652096e-01 | 0.576 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 2.652096e-01 | 0.576 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.652096e-01 | 0.576 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 2.652096e-01 | 0.576 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.652096e-01 | 0.576 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.652096e-01 | 0.576 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.652096e-01 | 0.576 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.652096e-01 | 0.576 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 2.652096e-01 | 0.576 | 0 | 0 |
| Beta-ketothiolase deficiency | R-HSA-9915355 | 2.652096e-01 | 0.576 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.652096e-01 | 0.576 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.652096e-01 | 0.576 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.652096e-01 | 0.576 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.652096e-01 | 0.576 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.677265e-01 | 0.572 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.695671e-01 | 0.569 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.729947e-01 | 0.564 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.729947e-01 | 0.564 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.729947e-01 | 0.564 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.732565e-01 | 0.563 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.740837e-01 | 0.562 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.742264e-01 | 0.562 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.742264e-01 | 0.562 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.742264e-01 | 0.562 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.742264e-01 | 0.562 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.742264e-01 | 0.562 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.742264e-01 | 0.562 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.742264e-01 | 0.562 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.785044e-01 | 0.555 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.785044e-01 | 0.555 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.793693e-01 | 0.554 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.793693e-01 | 0.554 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.793693e-01 | 0.554 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.824693e-01 | 0.549 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 2.824693e-01 | 0.549 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.827761e-01 | 0.549 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.827761e-01 | 0.549 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.827761e-01 | 0.549 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.827761e-01 | 0.549 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.827761e-01 | 0.549 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.845266e-01 | 0.546 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.845266e-01 | 0.546 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.925180e-01 | 0.534 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.925180e-01 | 0.534 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.931162e-01 | 0.533 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.931162e-01 | 0.533 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.973919e-01 | 0.527 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.002755e-01 | 0.522 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.020797e-01 | 0.520 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.020797e-01 | 0.520 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.090902e-01 | 0.510 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.102076e-01 | 0.508 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.102076e-01 | 0.508 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.102076e-01 | 0.508 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.102076e-01 | 0.508 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.104037e-01 | 0.508 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 3.104218e-01 | 0.508 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.119012e-01 | 0.506 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.119012e-01 | 0.506 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.119012e-01 | 0.506 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.119012e-01 | 0.506 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.119012e-01 | 0.506 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.119012e-01 | 0.506 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.122704e-01 | 0.505 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.137582e-01 | 0.503 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.151710e-01 | 0.501 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.179688e-01 | 0.498 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.211715e-01 | 0.493 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.235450e-01 | 0.490 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.249838e-01 | 0.488 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.249838e-01 | 0.488 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.249838e-01 | 0.488 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.321913e-01 | 0.479 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.321913e-01 | 0.479 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.321913e-01 | 0.479 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.358130e-01 | 0.474 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.358130e-01 | 0.474 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.358130e-01 | 0.474 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.358130e-01 | 0.474 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.358130e-01 | 0.474 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 3.369508e-01 | 0.472 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.369508e-01 | 0.472 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.369508e-01 | 0.472 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.369508e-01 | 0.472 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 3.369508e-01 | 0.472 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.369508e-01 | 0.472 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.369508e-01 | 0.472 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.369508e-01 | 0.472 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.369508e-01 | 0.472 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.374620e-01 | 0.472 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.376158e-01 | 0.472 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.380199e-01 | 0.471 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.380199e-01 | 0.471 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.479917e-01 | 0.458 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.479917e-01 | 0.458 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.479917e-01 | 0.458 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.479917e-01 | 0.458 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.491408e-01 | 0.457 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.491408e-01 | 0.457 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.491408e-01 | 0.457 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.491408e-01 | 0.457 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.491408e-01 | 0.457 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.491408e-01 | 0.457 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.491408e-01 | 0.457 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 3.491408e-01 | 0.457 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.491408e-01 | 0.457 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.491408e-01 | 0.457 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.491408e-01 | 0.457 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.491408e-01 | 0.457 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.491408e-01 | 0.457 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.522217e-01 | 0.453 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.529860e-01 | 0.452 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.537658e-01 | 0.451 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.537658e-01 | 0.451 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.537658e-01 | 0.451 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.537658e-01 | 0.451 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.537658e-01 | 0.451 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.538583e-01 | 0.451 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.609883e-01 | 0.443 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.657597e-01 | 0.437 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.673024e-01 | 0.435 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.673024e-01 | 0.435 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.681123e-01 | 0.434 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.703287e-01 | 0.431 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.717861e-01 | 0.430 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.717861e-01 | 0.430 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.723048e-01 | 0.429 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.856713e-01 | 0.414 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.856713e-01 | 0.414 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.856713e-01 | 0.414 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.856713e-01 | 0.414 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.856713e-01 | 0.414 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.856713e-01 | 0.414 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.856713e-01 | 0.414 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.856713e-01 | 0.414 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.856713e-01 | 0.414 | 0 | 0 |
| Disease | R-HSA-1643685 | 3.871427e-01 | 0.412 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.898339e-01 | 0.409 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.898339e-01 | 0.409 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.898339e-01 | 0.409 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.898339e-01 | 0.409 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.923864e-01 | 0.406 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.932953e-01 | 0.405 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.939845e-01 | 0.405 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.939845e-01 | 0.405 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 4.016914e-01 | 0.396 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.016914e-01 | 0.396 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.016914e-01 | 0.396 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.016914e-01 | 0.396 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.016914e-01 | 0.396 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.016914e-01 | 0.396 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.016914e-01 | 0.396 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.016914e-01 | 0.396 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.016914e-01 | 0.396 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.016914e-01 | 0.396 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.043963e-01 | 0.393 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.124148e-01 | 0.385 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 4.124148e-01 | 0.385 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.124148e-01 | 0.385 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.168162e-01 | 0.380 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.168162e-01 | 0.380 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.168162e-01 | 0.380 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.168162e-01 | 0.380 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.198806e-01 | 0.377 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.198806e-01 | 0.377 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.205101e-01 | 0.376 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.205101e-01 | 0.376 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.212763e-01 | 0.375 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.212763e-01 | 0.375 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.212763e-01 | 0.375 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.212763e-01 | 0.375 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.212763e-01 | 0.375 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.212763e-01 | 0.375 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.212763e-01 | 0.375 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.212763e-01 | 0.375 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.212763e-01 | 0.375 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.258599e-01 | 0.371 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.296288e-01 | 0.367 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.323415e-01 | 0.364 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.323415e-01 | 0.364 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 4.323415e-01 | 0.364 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.323415e-01 | 0.364 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 4.363479e-01 | 0.360 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.394455e-01 | 0.357 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.394455e-01 | 0.357 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.394455e-01 | 0.357 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.394455e-01 | 0.357 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.394455e-01 | 0.357 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.394455e-01 | 0.357 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.473013e-01 | 0.349 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.473013e-01 | 0.349 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.473013e-01 | 0.349 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.473013e-01 | 0.349 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.473013e-01 | 0.349 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.521133e-01 | 0.345 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.521209e-01 | 0.345 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.521209e-01 | 0.345 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 4.557884e-01 | 0.341 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.557884e-01 | 0.341 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.557884e-01 | 0.341 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.557884e-01 | 0.341 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.557884e-01 | 0.341 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.557884e-01 | 0.341 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.557884e-01 | 0.341 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.557884e-01 | 0.341 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.601141e-01 | 0.337 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.601141e-01 | 0.337 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.601141e-01 | 0.337 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.601141e-01 | 0.337 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.601141e-01 | 0.337 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.601141e-01 | 0.337 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.601141e-01 | 0.337 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.601141e-01 | 0.337 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 4.601141e-01 | 0.337 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 4.601141e-01 | 0.337 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.601141e-01 | 0.337 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.601141e-01 | 0.337 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.601141e-01 | 0.337 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.613634e-01 | 0.336 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.615560e-01 | 0.336 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.615560e-01 | 0.336 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.615560e-01 | 0.336 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.618104e-01 | 0.336 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.618104e-01 | 0.336 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.618104e-01 | 0.336 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.686810e-01 | 0.329 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 4.717104e-01 | 0.326 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 4.717104e-01 | 0.326 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.717104e-01 | 0.326 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.735799e-01 | 0.325 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.735799e-01 | 0.325 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.791983e-01 | 0.319 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 4.805498e-01 | 0.318 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 4.805498e-01 | 0.318 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.838550e-01 | 0.315 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 4.838550e-01 | 0.315 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.838550e-01 | 0.315 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.890817e-01 | 0.311 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.890817e-01 | 0.311 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.890817e-01 | 0.311 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.890817e-01 | 0.311 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.890817e-01 | 0.311 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.890817e-01 | 0.311 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.890817e-01 | 0.311 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.890817e-01 | 0.311 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.890817e-01 | 0.311 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.890817e-01 | 0.311 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.890817e-01 | 0.311 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.890817e-01 | 0.311 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.890817e-01 | 0.311 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 4.904080e-01 | 0.309 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.940917e-01 | 0.306 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.966636e-01 | 0.304 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.966636e-01 | 0.304 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.992698e-01 | 0.302 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.992698e-01 | 0.302 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.995198e-01 | 0.301 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.019488e-01 | 0.299 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.024120e-01 | 0.299 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.055288e-01 | 0.296 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.055288e-01 | 0.296 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.055288e-01 | 0.296 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.055288e-01 | 0.296 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.055288e-01 | 0.296 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.086310e-01 | 0.294 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.101661e-01 | 0.292 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.128352e-01 | 0.290 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.128352e-01 | 0.290 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.128352e-01 | 0.290 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.128352e-01 | 0.290 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.128352e-01 | 0.290 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.128352e-01 | 0.290 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.128352e-01 | 0.290 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.128352e-01 | 0.290 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.128352e-01 | 0.290 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.128352e-01 | 0.290 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 5.128352e-01 | 0.290 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.199550e-01 | 0.284 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.210651e-01 | 0.283 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.210651e-01 | 0.283 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.210651e-01 | 0.283 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.210651e-01 | 0.283 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.210651e-01 | 0.283 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.210651e-01 | 0.283 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.210651e-01 | 0.283 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.210651e-01 | 0.283 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.210651e-01 | 0.283 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.210651e-01 | 0.283 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.224999e-01 | 0.282 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.238161e-01 | 0.281 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 5.243067e-01 | 0.280 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 5.243067e-01 | 0.280 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.243067e-01 | 0.280 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 5.243067e-01 | 0.280 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 5.248294e-01 | 0.280 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.289633e-01 | 0.277 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.309553e-01 | 0.275 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.309553e-01 | 0.275 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.328143e-01 | 0.273 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.376384e-01 | 0.270 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.474328e-01 | 0.262 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 5.486376e-01 | 0.261 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.490101e-01 | 0.260 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.498236e-01 | 0.260 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.516771e-01 | 0.258 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.516771e-01 | 0.258 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.516771e-01 | 0.258 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.516771e-01 | 0.258 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.516771e-01 | 0.258 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.516771e-01 | 0.258 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.516771e-01 | 0.258 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.563731e-01 | 0.255 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.604107e-01 | 0.251 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.604107e-01 | 0.251 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.604107e-01 | 0.251 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.604107e-01 | 0.251 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 5.604107e-01 | 0.251 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.604107e-01 | 0.251 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.604107e-01 | 0.251 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.604107e-01 | 0.251 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.604107e-01 | 0.251 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.604107e-01 | 0.251 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.604107e-01 | 0.251 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.604107e-01 | 0.251 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.604107e-01 | 0.251 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.604107e-01 | 0.251 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.604107e-01 | 0.251 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.604107e-01 | 0.251 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.634291e-01 | 0.249 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.637426e-01 | 0.249 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.641572e-01 | 0.249 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.642363e-01 | 0.249 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.642363e-01 | 0.249 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.655480e-01 | 0.248 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.655480e-01 | 0.248 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.655480e-01 | 0.248 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 5.655480e-01 | 0.248 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.679074e-01 | 0.246 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.679074e-01 | 0.246 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.722199e-01 | 0.242 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.767237e-01 | 0.239 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.773220e-01 | 0.239 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.785686e-01 | 0.238 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.808803e-01 | 0.236 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.808803e-01 | 0.236 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.808803e-01 | 0.236 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 5.811774e-01 | 0.236 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.866158e-01 | 0.232 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.877063e-01 | 0.231 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.933336e-01 | 0.227 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.950200e-01 | 0.225 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.006245e-01 | 0.221 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.006245e-01 | 0.221 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.006245e-01 | 0.221 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.006869e-01 | 0.221 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.033426e-01 | 0.219 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.033426e-01 | 0.219 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.033426e-01 | 0.219 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.033426e-01 | 0.219 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.033426e-01 | 0.219 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.033426e-01 | 0.219 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.033426e-01 | 0.219 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.033426e-01 | 0.219 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.033426e-01 | 0.219 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.033426e-01 | 0.219 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.033426e-01 | 0.219 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.033426e-01 | 0.219 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.047854e-01 | 0.218 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.069642e-01 | 0.217 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.078321e-01 | 0.216 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.086582e-01 | 0.216 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.086582e-01 | 0.216 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.086582e-01 | 0.216 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.086582e-01 | 0.216 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.086582e-01 | 0.216 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.086582e-01 | 0.216 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 6.086582e-01 | 0.216 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.086582e-01 | 0.216 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.086582e-01 | 0.216 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 6.086582e-01 | 0.216 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.119154e-01 | 0.213 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.170132e-01 | 0.210 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.170132e-01 | 0.210 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.170132e-01 | 0.210 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.170132e-01 | 0.210 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.175476e-01 | 0.209 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.228154e-01 | 0.206 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.256613e-01 | 0.204 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.276214e-01 | 0.202 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.340395e-01 | 0.198 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.340395e-01 | 0.198 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.350104e-01 | 0.197 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.350104e-01 | 0.197 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.350104e-01 | 0.197 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.350104e-01 | 0.197 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.350104e-01 | 0.197 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.350104e-01 | 0.197 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.350104e-01 | 0.197 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.381823e-01 | 0.195 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.381823e-01 | 0.195 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.381823e-01 | 0.195 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.381823e-01 | 0.195 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.420840e-01 | 0.192 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.420840e-01 | 0.192 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.420840e-01 | 0.192 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.420840e-01 | 0.192 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.420840e-01 | 0.192 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.420840e-01 | 0.192 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.420840e-01 | 0.192 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.420840e-01 | 0.192 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.420840e-01 | 0.192 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.420840e-01 | 0.192 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.420840e-01 | 0.192 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.465160e-01 | 0.189 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.494331e-01 | 0.187 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.585170e-01 | 0.181 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 6.585170e-01 | 0.181 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.585170e-01 | 0.181 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 6.599505e-01 | 0.180 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.599505e-01 | 0.180 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.599505e-01 | 0.180 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.599505e-01 | 0.180 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.599505e-01 | 0.180 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.691893e-01 | 0.174 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.706918e-01 | 0.173 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.770435e-01 | 0.169 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.770435e-01 | 0.169 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.770435e-01 | 0.169 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.770435e-01 | 0.169 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.770435e-01 | 0.169 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.770435e-01 | 0.169 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.770435e-01 | 0.169 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.770435e-01 | 0.169 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.770435e-01 | 0.169 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.780131e-01 | 0.169 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.808165e-01 | 0.167 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.835029e-01 | 0.165 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.835029e-01 | 0.165 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.835029e-01 | 0.165 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.835029e-01 | 0.165 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.835029e-01 | 0.165 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.835029e-01 | 0.165 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.844625e-01 | 0.165 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.886445e-01 | 0.162 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 6.945921e-01 | 0.158 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.057007e-01 | 0.151 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 7.057007e-01 | 0.151 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 7.057007e-01 | 0.151 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.057007e-01 | 0.151 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.059784e-01 | 0.151 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.085902e-01 | 0.150 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.085902e-01 | 0.150 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.085902e-01 | 0.150 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.085902e-01 | 0.150 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.085902e-01 | 0.150 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.085902e-01 | 0.150 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.085902e-01 | 0.150 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.085902e-01 | 0.150 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.085902e-01 | 0.150 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.085902e-01 | 0.150 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.096802e-01 | 0.149 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.096802e-01 | 0.149 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.103282e-01 | 0.149 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.103282e-01 | 0.149 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.108540e-01 | 0.148 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.108540e-01 | 0.148 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.144986e-01 | 0.146 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.144986e-01 | 0.146 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.234051e-01 | 0.141 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.234686e-01 | 0.141 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.234686e-01 | 0.141 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.234686e-01 | 0.141 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.254635e-01 | 0.139 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.265837e-01 | 0.139 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.265837e-01 | 0.139 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.265837e-01 | 0.139 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.265837e-01 | 0.139 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.293539e-01 | 0.137 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.315039e-01 | 0.136 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.370571e-01 | 0.132 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.370571e-01 | 0.132 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.370571e-01 | 0.132 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.370571e-01 | 0.132 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.370571e-01 | 0.132 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.370571e-01 | 0.132 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.370571e-01 | 0.132 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.370571e-01 | 0.132 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 7.395897e-01 | 0.131 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.400015e-01 | 0.131 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.400015e-01 | 0.131 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.402569e-01 | 0.131 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.416590e-01 | 0.130 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.461970e-01 | 0.127 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.461970e-01 | 0.127 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.461970e-01 | 0.127 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.475297e-01 | 0.126 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.478668e-01 | 0.126 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.531568e-01 | 0.123 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.539479e-01 | 0.123 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.539479e-01 | 0.123 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.558828e-01 | 0.122 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.589774e-01 | 0.120 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 7.627447e-01 | 0.118 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.627447e-01 | 0.118 | 0 | 0 |
| Utilization of Ketone Bodies | R-HSA-77108 | 7.627447e-01 | 0.118 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.627447e-01 | 0.118 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.627447e-01 | 0.118 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.627447e-01 | 0.118 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.627447e-01 | 0.118 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.627447e-01 | 0.118 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.627447e-01 | 0.118 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.627447e-01 | 0.118 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.645893e-01 | 0.117 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.645893e-01 | 0.117 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 7.645893e-01 | 0.117 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.645893e-01 | 0.117 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.689257e-01 | 0.114 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.736111e-01 | 0.111 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.777381e-01 | 0.109 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.777381e-01 | 0.109 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.783478e-01 | 0.109 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.800981e-01 | 0.108 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.800981e-01 | 0.108 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.818118e-01 | 0.107 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.818118e-01 | 0.107 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.818118e-01 | 0.107 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.818118e-01 | 0.107 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.818118e-01 | 0.107 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.859241e-01 | 0.105 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.859241e-01 | 0.105 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.859241e-01 | 0.105 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.859241e-01 | 0.105 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.859241e-01 | 0.105 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.859241e-01 | 0.105 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.859241e-01 | 0.105 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.859241e-01 | 0.105 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.859241e-01 | 0.105 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.864583e-01 | 0.104 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.907137e-01 | 0.102 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.916180e-01 | 0.101 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.916180e-01 | 0.101 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 7.916180e-01 | 0.101 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.920502e-01 | 0.101 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.923220e-01 | 0.101 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.959544e-01 | 0.099 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 7.979177e-01 | 0.098 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.979177e-01 | 0.098 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.979177e-01 | 0.098 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.979177e-01 | 0.098 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.984031e-01 | 0.098 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.033742e-01 | 0.095 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.039940e-01 | 0.095 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.039940e-01 | 0.095 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.039940e-01 | 0.095 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.065640e-01 | 0.093 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.068402e-01 | 0.093 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.068402e-01 | 0.093 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.068402e-01 | 0.093 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.068402e-01 | 0.093 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 8.068402e-01 | 0.093 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.068402e-01 | 0.093 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.068402e-01 | 0.093 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.068402e-01 | 0.093 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.068402e-01 | 0.093 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.068402e-01 | 0.093 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.129606e-01 | 0.090 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.129606e-01 | 0.090 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.163777e-01 | 0.088 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.163777e-01 | 0.088 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.163777e-01 | 0.088 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.172129e-01 | 0.088 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.229317e-01 | 0.085 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.257138e-01 | 0.083 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.257138e-01 | 0.083 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 8.257138e-01 | 0.083 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.257138e-01 | 0.083 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.257138e-01 | 0.083 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.257138e-01 | 0.083 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.257362e-01 | 0.083 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.257362e-01 | 0.083 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.261727e-01 | 0.083 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.269944e-01 | 0.082 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.269944e-01 | 0.082 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.269944e-01 | 0.082 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.269944e-01 | 0.082 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.269944e-01 | 0.082 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.269944e-01 | 0.082 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.359389e-01 | 0.078 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.370137e-01 | 0.077 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.400842e-01 | 0.076 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.400842e-01 | 0.076 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.427443e-01 | 0.074 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.427443e-01 | 0.074 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.427443e-01 | 0.074 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.427443e-01 | 0.074 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.427443e-01 | 0.074 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.427443e-01 | 0.074 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.454400e-01 | 0.073 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.522480e-01 | 0.069 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.522480e-01 | 0.069 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.522480e-01 | 0.069 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.545661e-01 | 0.068 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.546028e-01 | 0.068 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.581115e-01 | 0.066 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.581115e-01 | 0.066 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.581115e-01 | 0.066 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.581115e-01 | 0.066 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.581115e-01 | 0.066 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.581115e-01 | 0.066 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.581115e-01 | 0.066 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.581115e-01 | 0.066 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.581115e-01 | 0.066 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.581115e-01 | 0.066 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.604368e-01 | 0.065 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.607040e-01 | 0.065 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.635721e-01 | 0.064 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.635721e-01 | 0.064 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.635721e-01 | 0.064 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.635721e-01 | 0.064 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.657815e-01 | 0.063 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.697338e-01 | 0.061 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.707022e-01 | 0.060 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.719779e-01 | 0.059 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.719779e-01 | 0.059 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.719779e-01 | 0.059 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.719779e-01 | 0.059 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.719779e-01 | 0.059 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.719779e-01 | 0.059 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.719779e-01 | 0.059 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.719779e-01 | 0.059 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.719779e-01 | 0.059 | 0 | 0 |
| Mitochondrial Uncoupling | R-HSA-166187 | 8.719779e-01 | 0.059 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.719779e-01 | 0.059 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.719779e-01 | 0.059 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.719779e-01 | 0.059 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.740949e-01 | 0.058 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.740949e-01 | 0.058 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.784792e-01 | 0.056 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.826611e-01 | 0.054 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.838649e-01 | 0.054 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.838649e-01 | 0.054 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.838649e-01 | 0.054 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.844899e-01 | 0.053 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.844899e-01 | 0.053 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.844899e-01 | 0.053 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.844899e-01 | 0.053 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.844899e-01 | 0.053 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.844899e-01 | 0.053 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.844899e-01 | 0.053 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.908735e-01 | 0.050 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.929286e-01 | 0.049 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.929286e-01 | 0.049 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.935911e-01 | 0.049 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.957797e-01 | 0.048 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.957797e-01 | 0.048 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.957797e-01 | 0.048 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.957797e-01 | 0.048 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.957797e-01 | 0.048 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.957797e-01 | 0.048 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.957797e-01 | 0.048 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.979077e-01 | 0.047 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.979077e-01 | 0.047 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.001902e-01 | 0.046 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.001902e-01 | 0.046 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.013308e-01 | 0.045 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.013308e-01 | 0.045 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.015876e-01 | 0.045 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.016607e-01 | 0.045 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.059666e-01 | 0.043 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.059666e-01 | 0.043 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.059666e-01 | 0.043 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.059666e-01 | 0.043 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.059666e-01 | 0.043 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.059666e-01 | 0.043 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.059666e-01 | 0.043 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.123127e-01 | 0.040 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.123127e-01 | 0.040 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.123127e-01 | 0.040 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.133916e-01 | 0.039 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.151584e-01 | 0.039 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.151584e-01 | 0.039 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.151584e-01 | 0.039 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.151584e-01 | 0.039 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.151584e-01 | 0.039 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.151584e-01 | 0.039 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.151584e-01 | 0.039 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 9.151584e-01 | 0.039 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.151584e-01 | 0.039 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.151584e-01 | 0.039 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.154101e-01 | 0.038 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.154101e-01 | 0.038 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.163192e-01 | 0.038 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.163192e-01 | 0.038 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.163192e-01 | 0.038 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.207730e-01 | 0.036 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.216741e-01 | 0.035 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.229848e-01 | 0.035 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.229848e-01 | 0.035 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.231054e-01 | 0.035 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.234522e-01 | 0.035 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.234522e-01 | 0.035 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.234522e-01 | 0.035 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.234522e-01 | 0.035 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.234522e-01 | 0.035 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.234522e-01 | 0.035 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 9.234522e-01 | 0.035 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.280410e-01 | 0.032 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.291474e-01 | 0.032 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.291474e-01 | 0.032 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.291474e-01 | 0.032 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.291474e-01 | 0.032 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.297429e-01 | 0.032 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.309356e-01 | 0.031 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.309356e-01 | 0.031 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.309356e-01 | 0.031 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.309356e-01 | 0.031 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.309356e-01 | 0.031 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.309356e-01 | 0.031 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.309356e-01 | 0.031 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.348416e-01 | 0.029 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.348416e-01 | 0.029 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.348416e-01 | 0.029 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.376879e-01 | 0.028 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.376879e-01 | 0.028 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.396257e-01 | 0.027 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.437222e-01 | 0.025 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.437804e-01 | 0.025 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.437804e-01 | 0.025 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.437804e-01 | 0.025 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.437804e-01 | 0.025 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.437804e-01 | 0.025 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.437804e-01 | 0.025 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.438080e-01 | 0.025 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.443279e-01 | 0.025 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.449537e-01 | 0.025 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.486794e-01 | 0.023 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 9.492775e-01 | 0.023 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.492775e-01 | 0.023 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.492775e-01 | 0.023 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.532423e-01 | 0.021 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.535597e-01 | 0.021 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.542374e-01 | 0.020 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.542374e-01 | 0.020 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.542374e-01 | 0.020 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.542374e-01 | 0.020 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.542374e-01 | 0.020 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.560917e-01 | 0.020 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.563160e-01 | 0.019 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.573647e-01 | 0.019 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.587125e-01 | 0.018 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.587125e-01 | 0.018 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.587125e-01 | 0.018 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.587125e-01 | 0.018 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.608700e-01 | 0.017 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.627503e-01 | 0.016 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.627503e-01 | 0.016 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.627503e-01 | 0.016 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.627503e-01 | 0.016 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.627503e-01 | 0.016 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.661890e-01 | 0.015 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.663934e-01 | 0.015 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.663934e-01 | 0.015 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.663934e-01 | 0.015 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.690044e-01 | 0.014 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.691794e-01 | 0.014 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.702540e-01 | 0.013 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.702540e-01 | 0.013 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.723160e-01 | 0.012 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.723160e-01 | 0.012 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.724820e-01 | 0.012 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.726461e-01 | 0.012 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.726461e-01 | 0.012 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.726461e-01 | 0.012 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.741047e-01 | 0.011 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.753218e-01 | 0.011 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.762735e-01 | 0.010 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.777360e-01 | 0.010 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.799141e-01 | 0.009 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.799141e-01 | 0.009 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.799141e-01 | 0.009 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.804955e-01 | 0.009 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.818792e-01 | 0.008 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.836273e-01 | 0.007 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.836522e-01 | 0.007 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.836522e-01 | 0.007 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.836522e-01 | 0.007 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.848729e-01 | 0.007 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.852518e-01 | 0.006 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.863091e-01 | 0.006 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.865254e-01 | 0.006 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.875101e-01 | 0.005 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.875701e-01 | 0.005 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.879970e-01 | 0.005 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.879970e-01 | 0.005 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.887700e-01 | 0.005 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.891717e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.891717e-01 | 0.005 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.891717e-01 | 0.005 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.891717e-01 | 0.005 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.894307e-01 | 0.005 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.902315e-01 | 0.004 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.902315e-01 | 0.004 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.902315e-01 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.910837e-01 | 0.004 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.911876e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.911876e-01 | 0.004 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.919973e-01 | 0.003 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.920502e-01 | 0.003 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.920502e-01 | 0.003 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.920502e-01 | 0.003 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.922219e-01 | 0.003 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.922582e-01 | 0.003 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.936248e-01 | 0.003 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.941638e-01 | 0.003 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.941638e-01 | 0.003 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.941638e-01 | 0.003 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.943426e-01 | 0.002 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.943426e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.944254e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.945048e-01 | 0.002 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.947352e-01 | 0.002 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.949093e-01 | 0.002 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.952507e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.952507e-01 | 0.002 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.957157e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.957567e-01 | 0.002 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.964651e-01 | 0.002 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.965137e-01 | 0.002 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.971632e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.973151e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.973151e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.974410e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.976513e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.976917e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.976917e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.976917e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.979632e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.983211e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.986215e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.988296e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.989853e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.989884e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.990816e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.990875e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.990875e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.990875e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.991769e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.994291e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.995081e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.995568e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.996414e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.996432e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.996635e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.996787e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.996839e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997067e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.997067e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.997355e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997355e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.997395e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.997611e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.997630e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.997785e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.997848e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998039e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.998039e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998059e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998174e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998568e-01 | 0.000 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.998576e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.998576e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.998716e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.998806e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.998956e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.998982e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.998992e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999035e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999438e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999441e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999574e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999628e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999837e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999868e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999922e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999944e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999962e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999964e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999979e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999981e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999982e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999986e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999990e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999993e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999994e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999996e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999996e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999997e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |